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Abstract 
 
 
Taxol is one of the world’s most successful drugs used in the treatment of cancers.  
Isolated from the bark of the Pacific yew tree (Taxus brevifolia), it is a molecule of great 
interest within organic chemistry; with six total syntheses and a number of synthetic works 
having been published since its discovery.   
 
A semi-convergent synthesis of an intermediate in Holton’s synthesis was planned.  The 
overall synthetic plan is shown below.  The A ring would be installed by an intramolecular 
pinacol condensation.  The BC bicycle would be closed by ring-closing metathesis at C10-
C11.  The ketone at C12 would be protected as an alkyne and the BC bicycle precursor 
would be obtained by coupling fragment A and the C ring.  
 
 
 
 
This thesis describes the preparation of a model C ring, without the oxygenated 
functionality at C7, was successfully synthesised along with fragment A.  Metathesis 
precursors were synthesised and gold hydration reactions were attempted. 
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1.1 Generalities of Taxol 
 
 
Paclitaxel, marketed as Taxol 1, together with docetaxel (Taxotere 2) are regarded as the 
top plant-based anti-cancer drugs in circulation in the world to date.  Sales of both taxol 
and taxotere took over 3.15 billion US dollars in 2010 alone[1] and with 1 in 4 deaths in the 
United States a result of cancer,[2] sales are likely to keep increasing.  Taxol is used to treat 
a variety of cancers including lung, ovarian, head and neck, and breast.[3]  Since its 
anticancer properties were discovered, taxol (Scheme 1.01) and its derivatives have 
become key treatments in the fight against cancer. 
 
 
 
Scheme 1.01 – Structure of Taxol and Taxotere 
 
1.2 Discovery of Taxol[4] 
 
In 1962, samples of bark, stem and needles were collected from the Pacific yew tree 
(Taxus brevifolia), as part of a program organised by the National Cancer Institute’s (NCI) 
Cancer Chemotherapy National Service Centre (CCNSC).  Plant samples were taken at 
random to be screened for anti-cancer properties and it was botanist Arthur Barclay who 
collected the samples from the evergreen tree Taxus brevifolia.  At the time not much was 
known about the tree other than that it was poisonous.     
 
In 1963, the crude extract from these woody samples was found to have cytotoxic activity 
against KB cells.  It was not until 1966 that Dr Monroe Wall at the Research Triangle 
Institute (RTI), along with his colleague Mansukh Wani, discovered that extracts from the 
bark of the tree were active against leukemia in mice.  Taxol was isolated in 1967, in a 
0.01% yield, from the bark of the tree as the needles and wood contained much less taxol.       
 
Wall and Wani set about characterising the isolated compound but admitted early failure in 
1967; however, the slow process of determining the structure of taxol eventually paid off.  
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Using mass spectrometry, X-ray crystallography and NMR spectroscopy, Wall and Wani 
discovered that the structure of taxol was a large molecule connected to a small tail or side 
chain (Scheme 1.02).  This work was then published in 1971 in the Journal of American 
Chemical Society stressing the anticancer activities of this newly isolated molecule.[5] 
 
 
 
Scheme 1.02 – Cleavage of the side chain of taxol 
 
The discovery of taxol at this point was discouraging as it had only shown to have modest 
activity against various leukaemias, it was insoluble in water and was isolated in very low 
yields from the bark of a slow growing yew tree.  Further testing was therefore carried out 
by the NCI after Wall and Wani passed taxol onto them for further studies.  In the early 
1970s, results of bioassays carried out by the NCI proved to be crucial, especially toward 
the activity of taxol in a B16 mouse melanoma model.  In 1977, taxol was selected as a 
development candidate following its good activity against MX-1 and NX-1 mammory and 
colon xenografts in mice.   
 
Its mechanism of action was discovered in 1979, by Susan Horwitz,[6] when she found that 
taxol prevented the replication of cancerous cells by stabilising microtubules and 
preventing their depolymerisation.  As this was the first time this mode of action had ever 
been seen, the interest in taxol increased significantly.   
 
Taxol entered Phase I and Phase II clinical trials in 1985.  The trials showed the first signs 
that taxol was an efficient drug, exhibiting activity against melanomas in ovarian and 
breast cancers.  In 1992 the Food and Drug Administration (FDA) agreed to the use of 
taxol against ovarian cancer[7] and for treatment of breast cancer[8] in 1994.  Further 
clinical trials showed that taxol could also be effective in treating Kaposi’s sarcoma, as 
well as the treatment of other cancers when taken in association with drugs such as 
cisplatin.     
Taxol was playing a major part in the fight against cancer; however its availability was 
beginning to cause some problems.  The clinical trials alone had consumed over 25,000 
 4 
trees in order to extract taxol from the bark.  This harvest was affecting the population of 
the tree in the north-western part of the United States, which was not popular with 
ecologists.  It was becoming clear that harvesting taxol from the bark of the tree was not a 
possible long term option.  A new source of taxol had to be found. 
 
This new source came about when Pierre Potier and his group began collecting the needles 
of Taxus baccata, the European yew tree, and on analysing the samples found that they 
contained 10-deactylbaccatin III (10-DAB),[9] having the main structure of taxol without 
the side chain and the acetyl group at C10 (Scheme 1.03).  Using 10-DAB from the needles 
of the tree proved to be a renewable source towards the synthesis of taxol and in 1988 
Potier published the semi-synthesis of taxol[10] from 10-DAB isolated from the needles.  
During the semi-synthesis, Potier discovered an analogue of taxol, taxotere 2.[11] This 
intermediate differs from taxol at the C10 position where the acetyl group is replaced by a 
hydroxyl group, which increases the solubility of taxotere in water.  The side chain also 
differs from taxol as the benzoyl is replaced by a tert-butyloxycarbonyl.  After its clinical 
phase I trial in 1990, taxotere was approved by the FDA in 1996 for the treatment of breast 
cancer and is currently marketed by Sanofi.  Taxotere is produced by semi-synthesis, but 
taxol is produced by plant cell fermentation by Phyton Biotech, LLC, a DFB 
pharmaceuticals company for Bristol-Myers Squib. 
 
 
 
Scheme 1.03 – Structure of 10-DAB 
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1.3 Structure and nomenclature  
 
Since the isolation of the first taxane in 1856, over 350 taxanes have been isolated and 
characterised.[12]  Taxol is part of this large family of taxanes whose name comes from the 
genus Taxus of the yew tree, Taxus brevifolia.  The majority of taxanes have a basic 
diterpene structure that consists of a pentamethyl [9.3.1.0] tricyclopentadecane skeleton 
(Scheme 1.04). 
 
  
 
Scheme 1.04 – Pentamethyl [9.3.1.0] tricyclopentadecane skeleton 
   
Taxanes can be classified into many different groups, which include the nature of the 
oxygenated functions found between C2 and C4; a select few are listed below. 
 
The first group of taxanes (Scheme 1.05) is characterised by an exocyclic double bond 
found between the C4 and C20 position, as well as an oxygenated functionality at C5 6.  
Taxine B 7 is a member of this group of taxanes, it is the major cardiotoxic agent found in 
the yew tree. 
 
 
 
Scheme 1.05 – Taxanes with a C4(20) double bond 
 
The second group of taxanes is characterised by an epoxide found between C4 and C20 8 
(Scheme 1.06).  Baccatin I 9 is an example of these kinds of taxanes. 
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Scheme 1.06 – Taxanes with a C4(20) epoxide 
 
The third group can be characterised by an oxetane ring found at the C4 and C5 positions 
10 (Scheme 1.07).  10-Deacetylbaccatin III 3 (10-DAB) can be found in this group of 
taxanes. 
 
 
 
Scheme 1.07 – Taxanes with an oxetane ring 
 
The final group we will mention is made up of taxanes that do not encompass the 
traditional ABC tricycle system.  Abeo-taxoids 11 are thought to be formed from a 
transannular cyclisation different to that of normal taxoid biosynthesis.  Taxine A 12 is an 
example of these class of taxanes.    
 
 
 
Scheme 1.08 – Abeo taxanes 
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1.4 Biosynthesis 
  
The biosynthesis of taxol has been studied in great detail in order to understand the 
production of the substance within the plant.  Knowing this could then be used for the 
synthesis of taxol using cell cultures.  The first few steps of the biosynthesis were 
discovered by Croteau.[13]   
 
The first key step involved to synthesise taxol and other taxanes is the cyclisation of a 
diterpenoid precursor geranylgeranyl disphosphate 13 into taxa-4(5),11(12)-diene[3] 14 
(Scheme 1.09) which is catalysed by the enzyme taxadiene synthase (TS).  Many terpene 
synthases produce multiple products when undergoing plant secondary metabolism 
however, taxadiene synthase produces mainly taxa-4(5),11(12)-diene 14 with only small 
amounts of other taxadiene isomers being formed.[14] 
 
 
   
Scheme 1.09 – Formation of the taxol skeleton 
 
The second key step in the biosynthesis is thought to be hydroxylation at the C5 position 
(Scheme 1.10).  This occurs via an allylic rearrangement of the C4-C5 double bond 14 to 
the C4-C20 position 15 of the taxane ring using the enzyme cytochrome P450.   
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Scheme 1.10 – Oxidation at C5 with cytochrome P450 
 
A number of oxidations take place followed by esterification giving 2α,7β-dihydrotaxusin 
16.  The third key step is the formation of the oxetane ring, which occurs via an 
intramolecular exchange of the C5 α-acetoxy group (Scheme 1.11).  Taxadien-5α-ol-O-
acetyltransferase is the enzyme likely to be used during the formation of the oxetane ring. 
 
 
Scheme 1.11 – Formation of the oxetane ring 
 
The final steps involve the addition of the side chain to the taxane core which is essential 
for the biological activity of taxol.  The natural amino acid α-phenylalanine 17 is converted 
into β-phenylalanine 18 by the enzyme Peptidylglycine Alpha-amidating Monooxygenase 
(PAM) (Scheme 1.12).  CoA-ligase then activates β-phenylalanine to the corresponding 
CoA ester which is then transferred to baccatin III 19.  Hydroxylation at C2’ and finally a 
benzoylation at C3’ then gives taxol 1.[15] 
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Scheme 1.12 – Biosynthesis of the Taxol side chain 
 
 
1.5 Mode of Action 
 
When the mode of action was discovered by Susan Horwitz in 1979,[16] it was found to be 
a unique one.  Taxol is part of the same family of spindle poisons such as vinblastine and 
vincristine, both anticancer drugs, but its mode of action was different.  Mitotic spindle 
poisons act on the cell cycle, blocking cell division at mitosis which results in cell 
apoptosis.  However, taxol stabilises microtubule polymers, blocking mitosis, as 
chromosomes are unable to create the spindle during metaphase which evidently leads to 
cell apoptosis. 
 
Microtubules are a component of the cell cytoskeleton and are made of tubulin.  These 
hollow tubular polymers have an outer diameter of 24 nanometres, with an inner diameter 
of approximately 12 nanometres.  They can grow up to 25 micrometres in length.  Tubulin 
is a heterodimer consisting of an α-subunit and β-subunit.  Microtubules are a result of the 
head to tail self assembly of these tubulin dimers which form protofilaments, these in turn 
form the walls of the microtubule (Scheme 1.13).  Thirteen profilaments are needed to 
make a microtubule. 
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Scheme 1.13 – Structure of a microtubule[17] 
(Picture from Nat. Rev. Drug. Discov, 2010, ref 15) 
 
Formation of microtubules is driven by guanosine triphosphate (GTP) binding and 
hydrolysis at the exchangeable site found on the β-subunit; it can also bind to the α-subunit 
but this is a non-exchangeable site.  The two subunits are in equilibrium in the cell which is 
known as dynamic instability.  Microtubules are assembled at 37 °C in the presence of 
GTP and dissembled when the temperature is lowered and/or in the presence of calcium 
ions.   
 
When spindle poisons such as vinblastine or vincristine bind to the β-subunit of tubulin, 
this affects the equilibrium of the cell and prevents polymerisation.[18]  The mode of action 
of taxol is totally different to that of normal spindle poisons.  Instead of preventing 
polymerisation, taxol promotes it and prevents depolymerisation of the microtubules.  
Taxol can even promote tubulin assembly in the absence of GTP and at lower 
temperatures.  The most important discovery was that the microtubules formed in the 
presence of taxol were stable to depolymerisation in the presence of calcium ions and at 4 
°C, when both these conditions would normally allow depolymerisation to occur (Scheme 
1.14).      
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Scheme 1.14 – Stabilisation of microtubules 
 
Taxol enhancing tubulin polymerisation and mictrotubule stabilisation 
White line: no taxol added, Grey line: 10 µm taxol added.  CaCl2 (4 nM) is added at 30 min showing no 
destabilisation of the microtubule. 
(Scheme from J. Nat. Prod. 2004, 67, 136-138) 
 
Microtubules formed in the presence of taxol are narrower (22 nm outer diameter) than 
when formed under normal conditions due to only twelve protofilaments forming the 
microtubule.  These abnormal microtubules are located near the poles of the spindle and do 
not organise themselves into the metaphase position (Scheme 1.15).  Instead the abnormal 
microtubules replicate and form ball-shaped chromosomal masses; this lack of cellular 
organisation inhibits spindle formation and causes cell death.   
 
 
Scheme 1.15 – Taxol blocking cells during mitosis 
DNA from diploids cells (2C) and tetraploid cells (4C) after treatment with taxol.  DNA content did not 
change over the course of the experiment showing that taxol blocks cell division. 
(Scheme from J. Nat. Prod. 2004, 67, 136-138) 
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1.6 Structure and reactivity 
 
There have been numerous studies on the structural activity of taxol in order to understand 
its biological activity and therefore create new analogues.  Key points about the activity of 
taxol are shown below as detailed by Kingston[19] (Scheme 1.15).  Changes made to the top 
half of the molecule tend not to affect its activity whereas changes made to the bottom half 
of the molecule affect its reactivity greatly.  These changes would affect the way taxol 
binds to the β-tubulin subunit.     
 
 
 
Scheme 1.16 – Structure-activity relationship 
 
With the structural activity of taxol fully understood, this has led to novel analogues being 
synthesised, some of which are now available on the market as anti-cancer drugs, whilst 
some are still in clinical trials.  One of these new analogues, cabazitaxel 20 (Scheme 1.17) 
is marketed by Sanofi as Jevtana[20] and was recently approved by the FDA as a therapy for 
patients with prostate cancer, which was previously treated with docetaxol (taxotere).   
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Scheme 1.17 – Cabazitaxel 
 
Cabazitaxel has the ability to cross the blood brain barrier, unlike taxol and taxotere and is 
undergoing further studies to be used as a treatment for other diseases/cancers.  
 
 
1.7 Previous syntheses of taxol 
 
Due to its complex structure, taxol has been the target of many organic chemists since its 
discovery.  This interest has led to a variety of ways of synthesising taxol; numerous partial 
and total syntheses have been described.  Most of the interest in synthesising taxol has not 
been applied to its synthesis in industry however; it has led the way for new analogues, 
such as taxotere and cabazitaxel, to be discovered.   
 
 
1.7.1 Semi-synthesis of taxol 
 
Since taxol cannot be isolated in large yield from the bark of the yew tree, certain groups 
started looking into synthesising taxol from its more renewable source 10-DAB 3.  As 
mentioned before Potier and Greene[10] completed the semi-synthesis of taxol in 1988.  The 
hydroxyl group at C7 was selectively protected to give 7-TES baccatin III 21 followed by 
addition of the side chain using di-2-pyridyl carbonate (DPC) 22.  Hydrolysis of the side 
chain then gave taxol in a good yield (Scheme 1.18). 
 14 
 
 
Scheme 1.18 – Semisynthesis by Potier and Greene 
 
It was during this synthesis that Potier also synthesised taxotere.[21]  Potier applied the 
Sharpless vicinal oxyamination reaction to a cinnamate taxane derivative he had 
synthesised in order to add the side chain.  After some simple deprotections and removal of 
the trichloroethyloxycarbonyl group, taxotere was obtained (Scheme 1.19).   
 
 
 
Scheme 1.19 – Potier semisynthesis of taxotere 
 
Holton[22] and Ojima[23] also successfully added the side chain to 10-DAB 3; they opened 
an optically pure β-lactam to give the side chain 25 (Scheme 1.20).   
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Scheme 1.20 – Semisynthesis by Holton and Ojima 
 
 
1.7.2 Total syntheses of taxol 
 
A. Fragmentation methods of synthesising taxol or taxane derivatives 
 
The first breakthrough in the synthesis of taxol was achieved by Robert Holton.  In 1984, 
he used work carried out by Buchi[24] to synthesise a derivative of β-patchouli oxide[25] 
which he would then skeletally rearrange.  A few years later this work was then used to 
synthesise (-)-taxusin,[26] which has a skeletal system similar to taxol.  Natural β-
patchoulene oxide was converted to the homoallylic alcohol 26 in fourteen steps.  This 
compound was then transformed to the epoxide, which when treated with titanium 
tetrachloride and peracetic acid to give the AB system 27 (Scheme 1.21).  Using this 
method not only gave the AB bicycle but also placed five asymmetric centres on the 
molecule.  The C ring was installed via an intramolecular nucleophilic substitution of the 
tosylate, synthesised from intermediate 28.  The final five steps were carried out to give (-
)-taxusin 30 in a good yield.  
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Scheme 1.21 – Holton synthesis of (-)-taxusin 
 
Following on from the synthesis of (-)-taxusin, Holton completed the total synthesis of 
taxol in 1994,[27] using the same type of chemistry as had previously been carried out.  The 
starting material for taxol was the unnatural enantiomer of β-patchoulene oxide, 
synthesised in twelve steps from (-)-camphor and described by Buchi.[28]  The epoxide was 
transformed to the homoallylic alcohol 31 in four steps (Scheme 1.22).   
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Scheme 1.22 – Total synthesis of taxol by Holton 
 
This was then subjected to the same fragmentation as described in the synthesis of taxusin.  
Ketone 32 was then transformed into the carbonate 33, using lithium 2,2,6,6-
tetramethylpiperidide (LTMP), which was followed by a Chan rearrangement[29] (Scheme 
1.23) to give 34, before the hydroxylactone was transformed into ester 35.  To form the C 
ring a Dieckmann condensation was carried out giving 36 and following a further twenty 
steps the synthesis of taxol was complete.         
 
 18 
 
 
Scheme 1.23 - Chan rearrangement 
 
It was not only Holton who synthesised taxol starting from a natural product, Wender 
synthesised taxol from pinene,[30] an abundant and inexpensive starting material.  Pinene is 
easily oxidised in air giving verbenone which was then converted to the keto-aldehyde 37 
by addition of prenyl bromide followed by selective ozonolysis of the more electron rich 
double bond (Scheme 1.24).  Photochemical rearrangement of 37 gave the chrysanthenone 
derivative 38, and a further six steps gave the intermediate 39. 
 
Transformation to 40 was carried out using a fragmentation method similar to that of the 
rearrangement carried out by Holton, which gave Wender the AB bicycle skeleton of taxol.  
This bicycle is slightly more functionalised than Holton’s as it features the oxygenated 
positions at C2 and C9.  This was then transformed into the keto-aldehyde 41 in twelve 
steps.  An intramolecular aldol reaction formed the C ring 42, giving the oxygenated C7 
position with good stereoselectivity.  It took a further eight steps to complete the synthesis 
of taxol 1.  
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Scheme 1.24 – Total synthesis of taxol by Wender 
 
Using this kind of fragmentation has led to two total syntheses of taxol but other methods 
have also been applied.  Ring-opening methods were studied by Swindell and Arseniyadis.  
Swindell[31] carried out a Grob fragmentation using zinc[32] to give the BC bicycle of taxol 
from an intermediate synthesised using photochemistry (Scheme 1.25).   
 
 
 
Scheme 1.25 – Grob fragmentation by Swindell to form the BC bicycle 
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Arseniyadis[33] also carried out a Grob fragmentation in order to synthesise the BC bicycle 
of taxol in 2005.  The fragmentation precursor gave the BC bicycle 47 in good yield.  The 
A ring was closed using a samarium(II) iodide-mediated aldol reaction which produced a 
highly functional tricyclic taxoid skeleton 49 (Scheme 1.26). 
 
 
Scheme 1.26 – Synthesis of the BC bicycle by Arseniyadis 
 
B. Syntheses of taxol or its derivatives using the Diels-Alder reaction 
 
Diels-Alder reactions are more commonly used during the synthesis of polycyclic 
compounds; however intramolecular Diels-Alder (IMDA) reactions[34] have been applied 
to only a few syntheses toward the taxane skeleton.  In 1983 both Sakan[35] and Shea used 
IMDA reactions to synthesise the ABC tricycle of a simple taxane.  Shea[36] planned an 
IMDA reaction using a trienone as the precursor (Scheme 1.27).   
 
 
 
Scheme 1.27 – Planned IMDA reaction by Shea 
Many groups have studied this reaction although the problem was how to install the C ring 
using the Diels-Alder reaction.  Winkler[37] was the first to accomplish this and installed 
 21 
the A and C rings of taxane using Diels-Alder cycloaddition reactions.  The second Diels-
Alder reaction gave the ABC taxane tricycle 55 in a highly stereoselective fashion 
(Scheme 1.28). 
 
 
 
Scheme 1.28 – Synthesis of the taxane tricycle by Winkler 
 
The examples discussed so far do not have highly functionalised skeletons; however Shea, 
using work from Winkler, has synthesised a more functionalised taxane skeleton whilst 
synthesising taxusin.  This skeleton has the methyl at C8 present and a C9-C10 diol is in 
place.[38]  The C ring was incorporated using a Lewis acid-catalysed IMDA reaction of an 
aldehyde and butadiene (Scheme 1.29). 
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Scheme 1.29 – Taxusin tricycle by Shea 
 
More recently Baran[39] carried out a large scale (3.2 g) Diels-Alder reaction when working 
toward the synthesis of taxadienone, a simplified taxane intermediate which allows easy 
access to the taxane family skeleton.  The desired diketone 62 was synthesised in a 
moderate yield from the enantiopure precursor 61 (Scheme 1.30). 
 
 
 
Scheme 1.30 – Diels-Alder reaction towards taxadienone by Bara 
 
C. Convergent syntheses of taxol 
 
The above methods are useful if only the basic skeletal frame of taxol is required.  
However, in order to synthesise taxol many steps are needed in order to add the necessary 
functionality.  Many groups have developed a number of strategies towards the synthesis 
of taxol but a more convergent approach, where the functionalised A and C fragments are 
attached and then used to form the B ring, may seem more favourable.  Most of these 
convergent approaches close the B ring between either C9-C10 or C10-C11.     
 23 
Coupling between C9-C10 
 
In 1994, Nicolaou[40] synthesised taxol using a convergent synthesis.  The first key step is a 
Shapiro coupling carried out between the A ring hydrazone 63 and the C ring aldehyde 64.  
This is then transformed in five steps to give the dialdehyde 66, which undergoes a 
McMurry coupling in order to obtain the ABC tricycle 67.  Taxol 1 is obtained after a 
further sixteen steps as the side chain and functionalities at C13 and C5 still need to be 
added (Scheme 1.31).   
 
     
 
Scheme 1.31 – Synthesis of taxol by Nicolaou 
 
Kuwajima also proposed a coupling reaction between C9 and C10 in order to synthesise 
taxol.  The synthesis planned for a Mukaiyama aldol reaction between a vinyl sulfide and 
an acetal, which would be catalysed by a Lewis acid.  This strategy allowed Kuwajima to 
synthesise not only taxol[41] but taxusin[42] as well.  The synthesis, like Nicolaou’s, starts 
with the C ring 69, which is lithiated and added to the A ring 68 to give precursor 70.  A 
Mukaiyama aldol reaction then takes place to give the ABC tricycle skeleton 71 with an 
aromatic C ring.  The methyl group at the C8 position was introduced by the ring opening 
of the cyclopropane 72 after treatment with samarium diiodide to give 73.  Twenty-eight 
more steps were needed in order to complete the total synthesis of taxol (Scheme 1.32).        
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Scheme 1.32 – Formal synthesis of taxol by Kuwajima 
 
Closing the B ring between C9-C10 was also used in a formal synthesis of taxol by 
Takahashi[43] in 2006.  Coupling between the A ring 74 and C ring 75 gave intermediate 
76, which was transformed in a further six steps to give 77.  This intermediate undergoes 
an intramolecular alkylation of the protected cyanohydrin to give 78 in a moderate yield.  It 
then takes a further eleven steps to synthesise Baccatin III, thus completing the formal 
synthesis (Scheme 1.33).   
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Scheme 1.33 – Synthesis of Baccatin III by Takahashi 
 
 
Coupling between C10-C11 
 
Kishi[44] was the first to use a transition metal-mediated coupling to form the B ring 
between C10-C11.  This was achieved using Ni(II) and Cr(II) chloride[45] to form the ring 
via an intramolecular coupling between the vinyl iodide and the aldehyde (Scheme 1.34).   
 
 
 
Scheme 1.34 – Closure of the B ring by Kishi 
 
Closure of the B ring between C10 and C11 was also carried out by Danishefsky[46] in 
1995 during his approach to the total synthesis of taxol.  After transforming the Wieland-
Mischer ketone to the C ring and preparing the A ring, 81 and 82 were coupled together 
using the vinyl lithiated species of 82 to give 83.  Transformation to 84 in seven steps then 
allowed for a Heck coupling to take place in order to close the B ring of the taxane 
skeleton giving 85.  After a further thirteen transformations, Baccatin III 3 was synthesised 
and this was transformed into taxol (Scheme 1.35). 
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Scheme 1.35 – Synthesis of taxol by Danishefsky 
 
 
Coupling between C1-C2 
 
Other routes of forming the eight-membered B ring of taxol have been studied; these 
examples look at closing the ring between C1 and C2.  Swindell[47] proposed a pinacol 
coupling using samarium diiodide between a ketone at C1 and an aldehyde at C2.  This 
was carried out on an intermediate without the oxygen functionalisation at C7 but did 
incorporate the methyl group at C8 (Scheme 1.36). 
 
 
 
Scheme 1.36 – Closure of the B ring using a pinacol coupling 
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Arseniyadis[48] synthesised the B ring using an aldol reaction between an aldehyde at C2 
and a ketone at C14.  Despite giving a poor yield, this ABC tricycle has some 
functionalisation but lacks the oxygen functionality at C1 and generates the wrong 
diastereomer at C3 (Scheme 1.37).    
 
 
 
Scheme 1.37 – Closure of the B ring using an aldol reaction 
 
D. Other examples towards taxol 
 
The last of the six total syntheses of taxol falls under this category.  Mukaiyama[49] 
synthesised taxol using a linear synthesis based on forming the B ring and adding the rest 
of the structure around it.  L-Serine was transformed in eighteen steps to give the aldehyde 
90.  The B ring was then formed by an intramolecular Reformatsky reaction using 
samarium diiodide to give 91.  This was then transformed in five steps to give 92, which 
underwent an aldol reaction to form the BC bicycle 93 in good yield.  A further ten 
transformations led to 94, which underwent a pinacol coupling using titanium chloride in 
order to form the A ring 95.  A further twenty steps resulted in the synthesis of taxol 1 
(Scheme 1.38). 
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Scheme 1.38 –Total synthesis of taxol by Mukaiyama 
 
There are many different ways to synthesise the ABC tricycle of taxol, some more 
successful than others.  Despite these previous attempts no one has synthesised taxol using 
olefin metathesis.  This could be a key development in synthesising the B ring with all its 
functionalities and could lead to other new analogues of taxol being discovered.   
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1.8 Cyclooctene formation using metathesis reactions 
 
1.8.1 Introduction to metathesis 
 
Metathesis comes from the Greek meaning ‘change of position’ and it promotes skeletal 
rearrangements between carbon atoms.[50]  It is a powerful tool used in synthetic organic 
chemistry.  In 2006, the Nobel prize for Chemistry was won by three researchers who had 
worked on the metathesis reaction.  Yves Chauvin[51] studied the mechanism of the 
reaction whilst Richard Schrock[52] and Robert Grubbs[53] developed catalysts that 
increased the efficiency of the reaction.   
 
Olefin metathesis can be classified into four groups: cross-metathesis (CM), ring-closing 
metathesis (RCM), ring opening metathesis (ROM) and acyclic diene metathesis 
(ADMET).  Cross metathesis allows C1=C2 and C3=C4 to be transformed into C1=C3 and 
C2=C4 and all reactions are, in principle, reversible.  The most commonly used type of 
metathesis is RCM, where terminal alkenes react using a catalyst to generate a cyclic olefin 
(Scheme 1.39).  A smaller olefin is released during this reaction. 
 
 
    
Scheme 1.39 – RCM catalytic cycle 
 
The mechanism of this reaction was discovered by Chauvin[54] in 1971 and as shown 
above, involves a sequence of [2+2] cycloadditions/cycloreversions of the metallic carbene 
and metallacyclobutane.  The steps in the mechanism are reversible, however the reaction 
entropically favours the catalytic process as the ethylene group produced is highly volatile.  
Since the discovery of the mechanism many catalysts have been developed in order to 
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improve the reaction.  The first catalysts, designed by Schrock between 1980 and 1990, 
were compounds containing either tungsten or molybdenum as these were found to be 
efficient in catalysing the reaction.  However, these catalysts had their drawbacks, they 
were highly sensitive to air and moisture and they reacted with other functional groups 
present in the substrate.  Grubbs developed a number of catalysts containing ruthenium, 
which were more stable in air and did not react with the other functional groups present in 
the substrate (Scheme 1.40). 
 
 
 
Scheme 1.40 – Metathesis catalysts 
 
Grubbs’ catalysts contain the neutral ruthenium atom in an oxidation state (II) and have 
sixteen electrons in the external orbital.  The metal ion is normally coordinating one or 
more electron rich phosphine species, such as PCy3.  Grubbs proposed a slightly more 
detailed mechanism than Chauvin, suggesting the electron-rich phosphine atom 
participates using a dissociation-association pathway.[55]     The first step is the dissociation 
of a phosphine ligand, this then generates the active carbene species that has fourteen 
electrons.  The metal complex enters the catalytic cycle and forms an adduct with the 
olefin which contains sixteen electrons.  The metallocyclobutane which is then formed is a 
new active species containing fourteen electrons, dissociation then allows the release of the 
metathesis product (Scheme 1.41). 
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Scheme 1.41 – Metathesis mechanism by Grubbs 
 
 
1.8.2 Formation of cyclooctenes by ring-closing metathesis[56] 
 
Synthesising eight-membered rings from acyclic precursors is a challenging problem faced 
by organic chemists.  This is due to the amount of strain and the number of transannular 
interactions which are entropically unfavourable when forming the ring.   
 
Conformations of an eight membered ring can be separated into three groups:[57] boat-
chair, crown and boat-boat (Scheme 1.42).  The interconversion between the 
conformations depends on the substituents found on the ring.  The boat-chair conformation 
represents the most stable conformer as transannular interactions are minimised. 
   
 
 
Scheme 1.42 – Conformations of cyclooctene 
 
Ring-closing metathesis has become a powerful and versatile tool for the selective 
formation of cyclic compounds.  Grubbs[58] was the first to use metathesis methods in an 
attempt to synthesise an eight-membered ring in 1995 (Scheme 1.43).  The initial work was 
not successful and produced only dimerisation products, despite the reactions being carried 
out at high dilution. 
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R1 R2 R3 R4 R5 Cataylst Yield  
Me OTES H H H G0 0% 
H H CO2Et CO2Et H S/G1 0% 
H H CO2Et CO2Et Me S/G1 0% 
 
Scheme 1.43 – First tests by Grubbs 
 
Despite these early failures, cyclisation could be realised by introducing conformational 
constraints, such as a ring that was already in place or using sterically hindered 1,2-
disubstitents.  An example of this was carried out by Grubbs, that involved a 1,2-trans-
disubstitued cyclohexane (Scheme 1.44).  It was presumed that the two olefins reacted due 
to their proximity as a resultant of the fused ring constrains.  The cis-disubstituted isomer 
was a poorer substrate and gave a lower yield of the desired cycloocetene, together with 
some starting material and some side products.   
 
 
 
Scheme 1.44 – Influence of conformational restraints 
 
Fürstner then applied this theory towards his synthesis of dactylol.[59]  The eight-membered 
ring was formed in the presence of a fused five-membered ring and a gem-dimethyl group 
(Scheme 1.45) giving the product in an excellent yield.   
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Scheme 1.45 – Synthesis of Dactylol by Fürstner 
 
Tori[60] tested ring-closing metathesis reactions on four diastereomers that had an epoxide 
present, in his attempt to synthesise YW3699.  Under the same conditions, only one 
diastereomer cyclised in an excellent yield; however the other three cyclisations were 
unsuccessul (Scheme 1.46).  This shows the importance of the configuration of the 
molecule and shows that there are difficulties when cyclising some highly substituted 
molecules. 
 
 
 
Scheme 1.46 – Cyclisation attempts by Tori 
 
Syntheses using RCM to obtain the B ring of taxol have been attempted previously.  The 
first has been carried out by Blechert when he was synthesising a model AB bicycle.[61]  
The precursor of the metathesis was obtained from (-)-β-pinene which was transformed to 
the enantiomerically pure A ring building block.  Two diastereoemers were formed and 
under metathesis conditions using Grubbs’ first catalyst, only one cyclised successfully, 
giving the desired AB bicycle model (Scheme 1.47).   
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Scheme 1.47 – Synthesis of model AB bicycle by Blechert 
 
Srikrishna[62] also carried out a successful metathesis reaction when synthesising a model 
BC ring of taxol.  This simplified bicycle with no functionality at C1-C2 and no gem-
dimethyl groups present, gave the cyclised product in excellent yield (Scheme 1.48). 
 
 
 
Scheme 1.48 – Metathesis of BC bicycle by Srikrishna 
 
These two examples show that metathesis reactions can be successfully applied when 
synthesising the B-ring of taxol.  The problem remains that some key functionalities of 
taxol are missing and whether or not ring-closing metathesis would occur on a more 
substituted precursor. 
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Chapter II 
 
Towards Taxol- Synthesis of fragment A and ring C 
 36 
2.1 Previous work in the lab 
 
2.1.1 First approach to taxol 
 
When the project started there were no publications about the total synthesis of taxol or the 
formation of cyclooctene rings using ring-closing metathesis.  A convergent synthesis was 
planned where the A and C rings would be prepared and coupled together before closing 
the B ring; a strategy employed used by Nicolaou in his total synthesis of taxol. 
 
Ring-closing metathesis between C9 and C10 would close the B ring and give the ABC 
tricycle.  The metathesis precursor would be obtained from the addition of the A ring to a 
vinyllithiated C ring.  The oxygenated functionalities would then be added by means of a 
dihydroxylation at C9-C10 and a hydroboration/oxidation sequence at C4 (Scheme 2.01). 
 
 
 
Scheme 2.01 – Proposed retrosynthesis 
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2.1.2 Work by Benoît Muller[63] 
 
A. Synthesis of the A ring 
 
A racemic model A ring with double bond functionality was synthesised.[64]  1,3-
Cyclohexanedione 106 was dimethylated and one ketone was protected giving 107.  
Another methylation procedure was then carried out followed by triflate formation which 
gave the precursor to the A ring 108 (Scheme 2.02).  
 
 
 
Scheme 2.02 – Synthesis of the vinyltriflate precursor 
 
Compound 108 then underwent a coupling reaction with vinylbutylstannane, which was 
followed by the hydrolysis of the cyclic ketal to produce the dienone 109 (Scheme 2.03).   
 
 
 
Scheme 2.03 – Synthesis of dienone 109 
 
Ketone 109 was then subjected to a cyanation reaction using trimethylsilyl cyanide in the 
presence of a catalytic amount of zinc iodide.  The cyanohydrin obtained was then reduced 
to the aldehyde using diisobutylaluminium hydride to give the A ring 110 (Scheme 2.04). 
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Scheme 2.04 – A ring aldehyde 110 
 
With the A ring successfully synthesised it could now be coupled with the model C ring. 
 
B. First coupling of the A and C rings 
 
The first couplings took place using the vinylbromide 111, which can easily be synthesised 
from 3-methylcyclohexanone.[65]  The coupling using tert-butyllithium gave only the trans 
product 112 (Scheme 2.05); this unusual selectivity will be discussed later on. 
 
 
 
Scheme 2.05 – Coupling of A and C rings 
 
Deprotection of the trimethysilyl ether gave the diol which was then transformed to the 
carbonate.  The spiroketal was deprotected to reveal ketone 113.  This was to be followed 
by a Michael addition of a vinyl group to synthesise the precursor for the metathesis 
reaction.  The Michael addition was unsuccessful, possibly due to steric hindrance around 
the enone (Scheme 2.06).      
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Scheme 2.06 – Michael addition trials 
 
A simpler model was then used to test the metathesis reaction.  A lithium derivative of 2-
bromostyrene 115 was added to the A ring.  The selectivity of the reaction was poor and a 
ratio of 2:1, in favour of the cis isomer, was obtained.  This could be resolved by carrying 
out the coupling on the α-hydroxy aldehyde 114, as the trans isomer 116 is the major 
product obtained after protection of the diol as a carbonate (Scheme 2.07).   
 
 
 
Scheme 2.07 – Model metathesis precursor 
 
C. Test metathesis reactions: closing the B ring 
 
A ring-closing metathesis reaction was carried out with the trienic carbonate however, in 
the presence of either Schrock or Grubbs first generation catalysts (and regardless of the 
temperature) no reaction occurred (Scheme 2.08).  There are several possible explanations 
to why this reaction was not working.  One reason could be the deactivation of the double 
bonds due to conjugation, it could also be because of the strain that would be present if the 
B ring was successfully formed, as well as the strain from gem-dimethyl group.   
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Scheme 2.08 – Metathesis tests 
 
Despite the metathesis reactions failing to form the B ring, the A ring had been synthesised 
successfully.   
2.1.3 Work by Damien Bourgeois[66] 
 
A. Convergent approach 
 
A convergent retrosynthesis was then envisaged, synthesising taxol from a tricyclic 
compound.  The B ring would be closed between C9 and C10 by ring-closing metathesis, 
whilst the precursor would be obtained by coupling the A and C rings (Scheme 2.09). 
 
   
 
Scheme 2.09 – Retrosynthesis for convergent approach 
 
A model C ring was synthesised using methyl cyclohexene, which was transformed into 
117 following a [2+2] cycloaddition.  Compound 117 underwent ring rearrangement and 
reduction to give 118, which was subjected to elimination, then oxidation, giving 119.  
Compound 119 was then transformed to the hydrazone 120 (Scheme 2.10).       
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Scheme 2.10 – Synthesis of the model C ring 
 
Compound 120 was then coupled together with 110 to give Shapiro adduct 121 in an 
excellent yield.  Deprotection of the trimethylsilyl group gave 122 (Scheme 2.11). 
 
 
 
Scheme 2.11 – Synthesis of diol 122 from the Shapiro reaction 
 
Compound 122 was then transformed into different metathesis precursors by protecting the 
diol with different groups (Scheme 2.12). 
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Scheme 2.12 – Preparation of metathesis precursors 
 
Despite using different catalysts and substoichiometric amounts (up to 50% of these 
catalysts) the metathesis reactions using precursors 123, 124 and 125 were unsuccessful 
and starting material was recovered (Scheme 2.13).  The catalyst did not react with either 
double bond, not even the one at C9, which is not conjugated as was previously.  However, 
the neopentylic double bond disfavours the metathesis reaction as it is sterically hindered, 
which could explain the lack of reactivity.   
 
 
 
Scheme 2.13 – Failed metathesis reactions 
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B. Semi-convergent approach 
 
A semi-convergent synthesis was then proposed, preparing taxol from a highly advanced 
intermediate previously described by Wender.  The A ring would be formed by an 
intramolecular aldol reaction, whilst the two oxygenated functions at C5 and C11 would be 
generated by a double allylic oxidation to give the desired oxygenated functionalities of the 
BC bicycle.  The B ring would be formed using ring-closing metathesis and the precursor 
would be prepared from a Shapiro coupling of fragment A and the C ring (Scheme 2.14).  
 
 
 
Scheme 2.14 – Semi-convergent retrosynthesis 
 
Fragment A was first synthesised; the ketal functionality was removed so that the Shapiro 
reaction could be tested on a simpler model.  The model fragment was prepared by adding 
t-butyllithium to commercially available 2,2-dimethylpent-4-enal.  This was then oxidised 
using Jones’ conditions to give the ketone 126.  Cyanation of 126 and reduction of the 
corresponding cyanohydrin then gave the aldehyde 127 which was used in the Shapiro 
reaction with hydrazone 128, previously synthesised, to give the BC bicycle skeleton 129 
with high stereoselectivity after deprotection of the trimethyl silyl group (Scheme 2.15). 
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Scheme 2.15 – Synthesis of diol 129 
 
The viability of the metathesis reaction, resulting in the formation of the B ring, was tested.  
Several metathesis precursors were prepared using various protecting groups for the diol 
(Scheme 2.16). 
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Scheme 2.16 – Synthesis of different metathesis precursors 
 
The first metathesis precursor to be tested was 130.  Using Grubbs’ first generation catalyst 
only the taxol-like isomer cyclised giving the desired ring closing between C9 and C10.  Its 
bicyclic isomer was also formed, resulting from migration of the double bond to the C10-
C11 position.  This isomer is more thermodynamically stable (ΔG = 3kcal mol-1).  The 
yields of the reactions were however quite low.  When using Nolan’s catalyst, the only 
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diastereomer that did cyclise had the wrong stereochemistry at C8 for taxol[67] (Scheme 
2.17). 
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Scheme 2.17 – Metathesis with mono-protected diol 130 
Ring-closing metathesis was then tested on cyclic silylene 131 and acetonide 132.  These 
two precursors cyclise efficiently using either Schrock’s or Nolan’s catalysts.  Grubbs’ 
first-generation catalyst did not produce any cyclisation products (Scheme 2.18). 
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Scheme 2.18 – Metathesis reactions with silylene 131 and acetonide 132  
Using the carbonate protected diol 133, in the presence of Grubbs’ first generation catalyst 
or Schrock’s catalyst, only one isomer cyclised.  Despite the desired taxol-like isomer 
forming, the geometry of the double bond is trans.  This was the first case of a trans 
cyclooctene ring being formed by ring-closing metathesis.[68]    Metathesis using Nolan’s 
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catalyst gave the cis diastereomer and in the presence of allyl ether; the trans diastereomer 
could be transformed to the cis diastereomer (Scheme 2.19).   
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Scheme 2.19 – Metathesis reactions with carbonate protected diol 
 
Bicycle β-Z-138 was then subjected to an oxidation using selenium dioxide and then 
Jones’ reagent in order to generate the oxygen functionalities at C5 and C11.  Oxidation at 
C11 proved to be difficult and failed, most probably due to the steric hinderance of the 
bulky gem-dimethyl group (Scheme 2.20).    
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Scheme 2.20 – Oxidation at C5 
 
In order to install the oxygen functionality at C11, it could be possible to take advantage of 
the more stabilised isomer with the alkene between C10 and C11 on the BC bicycle.  The 
bicycle β-Z-138 could be isomerised to 140 with rhodium(III) chloride. Dihydroxylation of 
the alkene followed by selective monoprotection of the diol before oxidation would take 
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place.  This would then produce a ketone in the C11 position, which would give the 
functionality necessary to form the A ring (Scheme 2.21). 
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Scheme 2.21 – Possible route to achieve functionality at C11 
 
A simpler option would be to synthesise the BC bicycle using ring-closing metathesis 
between C10 and C11, instead of isomerising the alkene between C9 and C10.  A new 
semi-convergent synthesis was designed, starting from an intermediate used by Holton in 
his taxol synthesis.  The A ring would be closed using an intramolecular aldol 
condensation.  The BC bicycle would again be formed using metathesis methods, and the 
precursor would be prepared from a new C ring and fragment A using a Shapiro reaction 
(Scheme 2.22).   
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Scheme 2.22 – Modified semi-convergent retrosynthesis 
 
2.1.4 Work by Stéphanie Schiltz[69] 
 
Fragment A was synthesised without any functionality at C13 and a 7-deoxy model C ring 
was prepared.  The commercially available starting material was valeraldehyde.  This was 
subjected to a Barbier reaction to give the alcohol 141, which was oxidised to give ketone 
142.  A cyanation reaction was carried out giving 143, which was reduced to the aldehyde 
144, thus completing the synthesis of fragment A (Scheme 2.23). 
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Scheme 2.23 – Synthesis of racemic model fragment A 
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The C ring precursor was synthesised employing an enantioselective Michael addition of 
an enantiopure enamine to methyl acrylate in order to define the stereochemistry of the 
methyl group at C8.[70]  2-Methylcyclohexanone was transformed in five steps to 146, this 
will be discussed in more detail later (Scheme 2.24).   
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Scheme 2.24 – Synthesis of ketone 146 
 
The Shapiro reaction proved to be difficult to optimise, so a different method was 
designed.  The ketone 146 was transformed into the vinyltriflate, which was submitted to a 
Stille coupling with hexamethyldistannane to give 148.  The vinyl bromide 149 was 
synthesised by a tin-bromide exchange (Scheme 2.25).   
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Scheme 2.25 – Synthesis of the vinyl bromide 149 
 
The vinyl bromide was then coupled with aldehyde 144 using tert-butyllithium to form the 
BC bicycle skeleton 150.  This produced two diastereomers in a 1:1 mixture, which were 
inseparable, in a 59% yield.  Treatment with acid then gave the two diols 151a and 151b, 
which were separated using flash column chromatography (Scheme 2.26).  151b is the 
isomer which possesses the required relative configuration for taxol. 
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Scheme 2.26 – Synthesis of diols 151a and 151b 
 
Both diastereomers were transformed separately into metathesis precursors.  The diols 
were protected as carbonates using carbonyl diimidazole.  The trityl protecting group was 
removed using Amberlyst H-15 to give the alcohols 153a and 153b.  Using Grieco’s 
reaction then gave the desired trienic carbonates 154a and 154b (Scheme 2.27).   
 
OTr
OH OH
151a
OTr
O O
O
OH
O O
O
O O
O
151b
CO2Im Amberlyst H-15
1. NO2PhSeCN
    PBu3
2. H2O2
152a 79%
152b 70%
153a 89%
153b 94%
154a 71%
154b 75%
 
 
Scheme 2.27 – Synthesis of trienes 154a/b 
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The two trienic carbonates were then subjected to ring-closing metathesis.  The non taxol-
like isomer 154a did not cyclise when using Grubbs’ first or second generation catalyst 
(Scheme 2.28).  Prolonged reaction time led to decomposition of the material. 
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Scheme 2.28 – Metathesis of the trienic compound 154a 
 
However, when triene 154b was treated with a catalytic quantity (30 mol%) of Grubbs’ 
first generation catalyst in 1,2-dichloroethane, the BC bicycle 155b was formed.  The 
single isomer gave the thermodynamic (Z) product in a 65% yield.  Using Grubbs’ second-
generation catalyst, or Nolan’s catalyst, proved to be more efficient and gave better yields 
with lower catalyst loadings, as well as reduced reaction times (Scheme 2.29). 
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Cat. Quantity Solvent Temperature Time Yield 
G1 30 mol% DCE 20 °C 5 days 65% 
G2 10 mol% DCE 80 °C 1 h 69% 
N 5 mol% DCE 80 °C 1 h 72% 
 
Scheme 2.29 – Metathesis with triene 154b 
 
With the success of the model C10-C11 route completed, work then continued toward the 
synthesis of fragments A and C that were necessary to synthesise taxol.   
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2.1.5 Work by Cong Ma[71a] 
 
A. Optimisation of the metathesis[72] 
 
The first aim was to improve the cyclisation reaction.  A number of different diols were 
studied.  The ketone 146 was transformed into the hydrazone, and a Shapiro reaction took 
place to give the BC bicycle skeleton in good yield (Scheme 2.30). 
 
OTr
O
OTr
NNHTris
OTr
OH OTMS
TrisNHNH2,
HCl cat.
96%
146 156 150
1. tBuLi
2. 144
80%
 
 
Scheme 2.30 – Synthesis of 150 by a Shapiro coupling 
 
After removal of the trimethylsilyl group, the two diols were separated.  The trityl groups 
were removed using Amberlyst H-15 to give triols 157a and 157b.  Trienes 158a and 158b 
were formed by protecting the diol with acetonide, whilst trienes 159a and 159b were 
formed by directly eliminating the primary alcohol using Grieco’s conditions.  Ammonium 
molybdate is used in the Grieco reaction so oxidation of the double bond between C3-C4 is 
prevented.  The carbonates 154a and 154b were opened using phenyllithium to obtain the 
benzoates 160a and 160b (Scheme 2.3`).    
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Scheme 2.31 – Synthesis of metathesis precursors 
 
With a variety of precursors now available, the metathesis reaction was studied.  The 
acetonide precursors were reacted with Grubbs’ second-generation catalyst.  After fifteen 
minutes in dichloromethane at reflux, the isomer 158a gave a mixture of dimeric products, 
the head-head and head-tail (Scheme 2.32).  Prolonged reaction time did not produce any 
cyclisation product. 
O O
158a
O O
OO
O O
O O
G2, 5 mol%
CH2Cl2, 
15 min
87%
161a
E/Z = 3:1
 
 
Scheme 2.32 – Metathesis with 158a 
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Cyclisation of the isomer 158b under the same conditions was extremely rapid and the BC 
bicycle was obtained in a quantitative yield after five minutes (Scheme 2.33). 
 
O O
158b
G2, 5 mol%
CH2Cl2, 
5 min
quant. O O
162b
 
 
Scheme 2.33 – Metathesis with 158b 
 
The diol precursors were tested but only 159b gave the desired cyclisation product when 
using Grubbs’ second-generation cataylst.  The other isomer degraded (Table 1). 
 
Table 1 – Metathesis with 159a/b 
 
OH OH
159
OH OH
Conditions
 
Isomer Catalyst Solvent Temperature Result 
a G2 Toluene 110 °C degradation 
b G1 Toluene 110 °C degradation 
b G2 CH2Cl2 40 °C quant. 
 
Both of the benzoate precursors cyclised when using either Grubbs’ first or second-
generation catalyst (Table 2).      
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Table 2 – Metathesis with 160a/b 
 
OH OBz
160
OH OBz
Conditions
 
Isomer Catalyst Solvent Temperature Duration Result 
a G1 CH3CH2Cl2 80 °C 36 h 71% 
a G2 CH2Cl2 40 °C 18 h 84% 
b G1 CH2Cl2 40 °C 12 h 78% 
b G2 CH2Cl2 20 °C 15 min quant. 
 
With tests on a number of precursors complete, the synthesis of fragments A and C 
necessary to synthesise the ABC tricycle of taxol was undertaken. 
 
B. Synthesis of fragment A 
 
The starting material was commercially available methyl-3-oxovalerate and the carbonyl at 
C13 would be protected as a ketal (Scheme 2.34). 
 
OTMS
CHO
O
OMe
OOCyanation
O
O
13
CN
OTMSOO OO
 
Scheme 2.34 – Fragment A retrosynthesis 
 
Methyl-3-oxovalerate was transformed to the ketal 162 in the presence of p-
toluenesulfonic acid, followed by the reduction of the ketal ester to give the aldehyde 163.  
The gem-dimethyl group was installed by a Barbier reaction giving 164 followed by 
oxidation of the alcohol to give 165.  Cyanation and trimethylsilyl protection of 165 gave 
166 (Scheme 2.35). 
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Scheme 2.35 – Synthesis of cyanohydrins 166 
 
Reduction of 166 with diisobutylaluminium hydride only gave a low yield of the desired 
aldehyde 167 and its derivative resulting from removal of the trimethylsilyl group (Scheme 
2.36).  The bulky ketal group, which is sterically hindered, was most likely to have 
affected the yield of the reaction. 
 
OO CNOTMS
166
OO OTMS
167
OO OH
O O
12%6%
DIBAL
168
 
 
Scheme 2.36 – Formation of 167 
 
A new route was then envisaged, this time masking the ketone as a protected secondary 
alcohol.  Methyl-3-oxovalerate was subjected to an enantioselective reduction using a high 
pressure hydrogen atmosphere (ten atm) in the presence of a ruthenium catalyst and (-)-
BINAP.[73]  The product was obtained with an excellent enantiomeric excess (Scheme 
2.37). 
 
OMe
OO [RuCl2(PPh3)2]2, (-)-BINAP
H2, 10 atm
quant.
OMe
OOH
ee > 99%
169
Methyl-3-oxovalerate
 
 
Scheme 2.37 – Enantioselective reduction 
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The alcohol was then protected as the para-methoxybenzyl ether.  The ester was reduced 
to the aldehyde 171 using diisobutylaluminium hydride.  A Barbier reaction then took 
place forming the homoallylic alcohol as a 1:1 mixture of diastereomers, which were 
oxidised to the ketone 173 (Scheme 2.38). 
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OOH
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Scheme 2.38 – Synthesis of ketone 173 
 
A cyanation reaction then took place with ketone 173 using trimethylsilyl cyanide and 
potassium cyanide.  Two equivalents of zinc iodide were used for the in situ deprotection 
of the para-methyloxybenzyl ether and to form the cyanohydrin 174, which was obtained 
as a single diastereomer.  The cyanide was then reduced to give the aldehyde 175 but it 
was difficult to isolate and a 20% yield was achieved only once (Scheme 2.39).     
 
O NC OTMS OTMS
O
ZnI2 (2 equiv.), KCN
TMSCN, then Et3N 20% over 
two steps
DIBAL
dr > 95:5
173 174 175
PMBO TMSO TMSO
 
Scheme 2.39 – Synthesis of aldehyde 175 
 
This aldehyde was not a successful candidate for the Shapiro reaction due to the 
irreproducibility of its synthesis.  A different strategy was then looked at but this time only 
the racemic fragment was synthesised. 
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C. New fragment A route 
 
This time the ketone at C12 was masked as an alkyne.  This alkyne would then undergo a 
hydroboration or gold hydration to unmask the ketone at a later stage.  The new fragment 
A started from commercially available 3-pentynol.   
 
3-Pentynol was transformed into aldehyde 177 in five steps which will be discussed in 
detail later (Scheme 2.40). 
 
 
 
Scheme 2.40 – Synthesis of racemic fragment A 
 
D. Towards 7-deoxytaxol 
 
Racemic fragment A 177 was then coupled together with the model C ring 156 in a 
Shapiro reaction.  Cerium trichloride titrated with butyllithium[74] was used in order to 
produce better yields of the coupling; this will be discussed in detail later.  After hydrolysis 
of the trimethylsilyl ether, the two diasteromers were separated giving 178a and 178b.  The 
two diols were then transformed into metathesis precursors 179a and 179b in four steps 
without any intermediate purifications (Scheme 2.41).    
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Scheme 2.41 – Synthesis of metathesis precursors 
 
The reaction with the two precursors using Grubbs’ second-generation catalyst did give a 
cyclised product just not the desired one.  Both isomers had undergone ene-yne-ene 
metathesis rather than the desired ene-ene metathesis.  This did however give a version of 
the ABC tricycle of taxol but with the gem-dimethyl group in the wrong position (Scheme 
2.42). 
 
 
 
Scheme 2.42 – Ene-yne-ene metathesis 
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Carbene formation starts at C10 and rotation around the C1 bond is followed by ene-yne 
metathesis to close the B ring; the A ring is then closed by ene-ene metathesis (Scheme 
2.43).  
 
 
 
Scheme 2.43 – Cyclisation mechanism 
 
This ene-yne-ene reaction has been observed before by Granja.[75]  In the presence of 
Grubbs’ second-generation catalyst, he formed the ABC tricycles (without the gem-
dimethyl group or the methyl at C8 position) from a simple skeleton in good yields 
(Scheme 2.44).  These models possess the wrong stereochemistry at C1 for taxol.     
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Scheme 2.44 – Synthesis of the ABC tricycle by Granja 
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In order to obtain the desired BC ring system, the alkyne needs to be transformed to the 
ketone before the ring-closing metathesis takes place. 
 
2.2 Aim of the project 
 
The aim of this project is to work towards the synthesis of the model 7-deoxy ABC tricycle 
of taxol.  Studies will be a continuation from work previously carried out in the lab by past 
members of the group.  I will be looking to close the B ring between C10 and C11 using 
RCM and avoid ene-yne-ene metathesis as seen previously.  The precursor to the 
metathesis reaction will be formed from a Shapiro coupling of two precursors: the A 
fragment and the C ring.       
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2.3 Modified retrosynthesis 
 
The previous retrosynthesis (Scheme 2.45) planned for ring-closing metathesis to take 
place before the unmasking of the ketone but as discussed, this allows ene-yne-ene 
metathesis to occur. 
 
  
 
Scheme 2.45 – Retrosynthesis of Cong Ma’s work 
 
The retrosynthesis has therefore been modified so that the ring-closing metathesis and 
hydroboration/hydration steps have been switched.  By unmasking the ketone before the 
metathesis step, the BC ring should close leaving the ketone at C12 ready to use to form 
the A ring at a later stage by a pinacol coupling with the ketone at C11 (Scheme 2.46).   
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Scheme 2.46 – Modified retrosynthesis 
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2.4 Towards the Shapiro coupling 
 
2.4.1 Synthesis of the model C ring 
 
A model 7-deoxy C ring was prepared in an enantiopure form through a chiral intermediate 
previously reported by d’Angelo[70] (Scheme 2.47) and enantiopure product 183 was 
obtained in good yield. 
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Scheme 2.47 – Proposed enantioselectivity control of chiral imine formation by d’Angelo 
 
This procedure was modified from the one previously used[71a] as that described purifying 
the enamine by distillation before adding the methyl acrylate.  This however proved to be 
difficult as distillation was not clean and prolonged heating degraded the enamine.  The 
enamine was concentrated and used crude for the reaction with methyl acrylate. 
 
D’Angelo proposed that the addition of chiral imines to electrophilic alkenes proceeds 
through a compact complex, where the tautomeric equilibrium of imine to enamine 
minimises the main steric interactions.  This was confirmed by deuterated experiments.  In 
the more substituted enamine, the syn N-H bond and double bond favoured internal 
concerted proton transfer, which is also stabilised by hyperconjugation of the methyl 
group.  Attack is favoured from the less hindered face of the enamine (anti to the bulky 
phenyl group), in its energetically favoured conformation (Figure 2.01).   
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Figure 2.01 – Approach from one face only 
 
Reduction of the keto ester 183 was then carried out using lithium aluminium hydride as 
described in the literature to give 146 as a 1:1 mixture of diastereomers.[76]  This was then 
followed by selective protection of the primary alcohol as the trityl ether 184 (Scheme 
2.48).   
 
 
 
Scheme 2.48 – Formation of trityl ether 184 
 
The trityl ether was obtained in good yield and the secondary alcohol underwent oxidation 
to the ketone using iodoxybenzoic acid in tetrahydrofuran and dimethylsulfoxide, which 
was stirred overnight at room temperature.  This gave the protected ketone 146 in good 
yield (Scheme 2.49).     
 
 
 
Scheme 2.49 – Oxidation of primary alcohol 184 
 
In order to carry out the Shapiro reaction, the hydrazone needed to be synthesised.  Trisyl 
hydrazine was prepared from a literature procedure (Scheme 2.50).[77] 
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Scheme 2.50 - Literature procedure 
 
The reaction using the literature precedent was repeated but the yields were still very low.  
Test reactions were carried out in order to synthesise the hydrazine in good yields as it is 
cheaper to make than purchase.  A number of different tests were carried out, mainly 
varying the number of equivalents of hydrazine hydrate added to the sulfonyl chloride.  
Results showed that adding five equivalents of hydrazine hydrate to the 
triisopropylsulfonyl chloride at -10 °C gave better yields and a pure white solid was 
formed (Scheme 2.51). 
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Scheme 2.51 - Modified hydrazine synthesis 
 
Formation of the trisylhydrazone from ketone 146 was then attempted.  When using the 
conditions previously developed in the group,[71a] the yield was only 30% (entry 1). In 
order to improve the yield of this reaction, different variables were tested (Table 3). 
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Table 3 – Test conditions for hydrazone formation using 1.44 mmol ketone 146 
 
 
Entry 
 
Equivalents 
of hydrazine 
 
THF mL 
Amount of 
conc. HCl 
added 
(drops) 
 
Reaction 
Time 
 
Yield 
1 1.0 5.0 2 1 h 30% 
2 1.0 5.0 4 1 h 40% 
3 1.1 5.0 4 1 h 42% 
4 1.1 5.0 0 2 h - 
5 1.1 5.0 2 2 h 38% 
6 1.1 5.0 4 16 h - 
7 1.2 5.0 4 2 h 53% 
8 1.1 5.0 4 2 h 71% 
9 1.1 10.0 4 2 h 87% 
 
The number of equivalents of hydrazine added was varied, and the best result was found to 
be when 1.1 equivalents were used (entries 2 vs 3 and 7 vs 8).  Varying the number of 
drops of concentrated acid to the reaction was crucial, too little or none and the reaction 
would not work (entries 4 and 5), too much and the reagents degraded.  Degradation was 
also a result of prolonged stirring (entry 6).  Adding 10 mL of tetrahydrofuran to the 
hydrazone and the ketone and ensuring they were completely dissolved before adding the 
acid gave the best result as after work up the yield had improved to 87% (entry 9) (Scheme 
2.52).   
  
 
Scheme 2.52 – Synthesis of hydrazone using optimised conditions 
 
A three-gram scale up was carried out however a low yield of 34% was obtained.  It was 
decided to carry out the reaction on a one-gram scale but carrying out multiple reactions at 
one time.  Material could then be brought through and purified together in one column. 
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With the hydrazone successfully synthesised, fragment A needed to be completed so that 
we had the two fragments for the Shapiro coupling. 
    
 
2.4.2 Synthesis of fragment A 
 
The starting material, 3-pentynol, was oxidised using Dess-Martin periodinane (DMP) 
which produced the desired aldehyde 187 (Scheme 2.53).  The iodoxy salt was precipitated 
out by cooling the solution to -78 °C and adding pentane.[78]  The crude product was 
recovered by filtering off the iodoxy salt through a silica gel plug and concentrated under 
vacuum.  The desired aldehyde is known to be unstable and has a low boiling point, which 
resulted in the loss of the aldehyde through the vacuum.  The reaction was repeated and 
concentration was again attempted, this time with ice in the water bath.  Despite the cooled 
bath, the aldehyde was again lost through the vacuum. 
 
 
 
 
Scheme 2.53 – DMP oxidation 
 
To prevent further loss, the aldehyde was not concentrated but left in solution.  3-Pentynol 
was again oxidised using Dess-Martin periodinane and cooled to -78 °C to precipitate out 
the iodoxy salt.  Pentane was not added as the aldehyde would already be diluted and this 
may affect the Barbier reaction that was to be carried out.  After filtration of the iodoxy 
salt, the crude aldehyde was left in solution.   
 
The diluted aldehyde was used in the Barbier reaction, which was carried out at room 
temperature (Scheme 2.54). 
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Scheme 2.54 – Barbier reaction to form 188 
 
The first attempt at this reaction gave a 60% yield, which may be a result of the diluted 
reagent.  The reaction was repeated using the same conditions as before, only to give a 
yield of 30%.  This dramatic decrease in the yield was thought to be due to the use of 
inactivated zinc dust.  The reaction was repeated again using activated zinc dust and the 
yield improved to 60%; however, another problem had occurred.   
 
The Barbier reaction uses 1-bromo-3-methylbut-2-ene, which has to be freshly prepared as 
it decomposes quickly.  The first time it was prepared a brown crude oil was obtained, 
which was then purified by distillation to give a clear oil.  This was then placed in the 
fridge overnight.  When retrieving the product the next day the clear oil had turned brown, 
showing signs of decomposition even when refrigerated.  This was thought to be a 
contributing factor to the low yields obtained during these early reactions.   
 
The solution to this was to use freshly prepared 1-bromo-3-methylbut-2-ene.  This proved 
to be more difficult than first thought.  The hydrobromic acid was added to the cooled 2-
methyl-3-buten-2-ol dropwise over half an hour.  This gave a clearer crude product before 
distillation but again problems started to occur.  Small distillation apparatus was used to 
reduce the loss of distilled product; however, the crude product would not distill over and 
excessive heating led to further decomposition.  Different sized distillation apparatus was 
used, as well as carrying out the distillation under vacuum.  Despite a few attempts at each 
of these methods pure 1-bromo-3-methylbut-2-ene could not be obtained.  
 
The 1H NMR spectrum of the crude product showed that it was cleaner when the 
hydrobromic acid was added dropwise to a cooled solution of methyl-3-buten-2-ol and did 
not require further purification.  The crude product was then used, in slight excess, in the 
Barbier reaction with the diluted aldehyde in dichloromethane.   
 
Another possible problem was that as the crude aldehyde 187 was diluted in solution and it 
could not be analysed for purity or yield by NMR techniques.  It was also possible that the 
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oxidation reaction of 3-pentynol may not have been complete or even successful.  First 
attempts at the oxidation of the alcohol were analysed by TLC, however the aldehyde spot 
was hard to see and the DMP reagent was seen as a large spot on the TLC plate.  The first 
few attempts gave low to moderate yields, which did not correspond to the yield obtained 
in the procedure that was being followed.  The DMP reagent was then examined.   
 
DMP was synthesised from IBX, previously synthesised and analysed for purity using 
NMR.  After workup the DMP reagent was analysed by 1H NMR techniques and was 
found to have some IBX impurities.  The reagent was washed with ether and analysed by 
1H NMR again.  The reagent was pure and was then used to oxidise the alcohol.  On 
adding two drops of water to the reaction the DMP is activated and the mixture would 
normally warm up.  However, on some occations this did not happen.  Additional DMP 
reagent was added and sometimes more drops of water were added.  The TLC plate was 
not clear when more DMP is added as it shows up as the largest spot, masking any starting 
material and product spots.  In order to improve the purity of the DMP the acetic anhydride 
used to synthesise it from IBX was distilled as it was thought that this could be affecting 
the quality of the reagent.  The freshly distilled acetic anhydride was used to synthesise 
DMP again and this seemed to improve the quality of the reagent.  On ordering a fresher 
bottle of acetic anhydride it was found that it did not need to be purified further and a purer 
batch of DMP was synthesised.  This was then used to oxidise the alcohol successfully, as 
seen by TLC once the DMP residues were removed and a small aliqot of the dilute 
aldehyde was obtained.  This was then used in the Barbier reaction.   
 
Despite the Barbier reaction being carried out in a mixture of solvents, the yield over two 
steps improved to 91% and gave the desired racemic alcohol 188.  This alcohol was 
oxidised using Dess-Martin periodinane and gave the ketone 176 in an excellent yield 
(Scheme 2.55). 
 
 
 
Scheme 2.55 – DMP oxidation to give the ketone 
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The ketone was then transformed into the racemic protected cyanohydrin[79] 189 (Scheme 
2.56) in an excellent yield.  Cyanation was carried out using catalytic zinc iodide and 
trimethylsilyl cyanide.    
 
 
 
Scheme 2.56 – Synthesis of racemic nitrile 
 
The racemic nitrile was then reduced with diisobutylaluminium hydride to give racemic 
aldehyde 177 (Scheme 2.57) following the procedure as carried out by Ma.[71a]  This is 
when we noticed problems starting to occur.  
 
 
 
Scheme 2.57 - DIBAL reduction of racemic nitrile 
 
This reaction should have given the desired aldehyde and when analysing the 1H NMR 
spectrum, should show an aldehyde peak around 9.60 ppm.  However, the 1H NMR 
spectrum of the first reaction showed two aldehyde peaks and starting material.  This did 
not correspond to the previous results obtained in the group.  The two compounds 
containing aldehydes were hard to separate by flash column chromatography as the Rf 
values were very similar.  The reaction was repeated with only two equivalents of DIBAL 
but again, the same two aldehyde peaks appeared on the NMR spectrum.     
 
A small amount of the desired aldehyde and the second aldehyde compound were 
eventually separated.  Analysis by 1H NMR showed that the trimethylsilyl group had been 
cleaved.  This could have occurred during the work up, when silica was added to the 
diluted reaction mixture and left in the freezer overnight.  This had not happened in 
previous reaction where this work up had been used and therefore needed to be 
investigated further.  However, the side product was identified, using COSY 1H NMR, as 
the over-reduced silyl ether 190 (Scheme 2.58).  
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Scheme 2.58 – Side product  
 
When studying the literature, this side product was not uncommon when using 
diisobutylaluminium hydride to reduce protected cyanohydrins.  Reid and Debiak-
Krook[80] had also encountered this over-reduced product whilst they were investigating 
the synthesis of corticoids.  They reduced a nitrile group to the corresponding aldehyde, 
using diisobutylaluminium hydride in dichloromethane, which gave them the over-reduced 
side product and the desired product as a 1:1 mixture (Scheme 2.59).   
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Scheme 2.59 – Over reduction as seen by Reid and Debiak-Krook 
 
They mentioned that solvent choice for this reaction was crucial.  In non chelating solvents 
such as dichloromethane or toluene, they discovered the level of the deoxy impurity ranged 
from 10 to 40%.  They also discovered that when using tetrahydrofuran, the level of 
impurity was less than 1% but the reaction was very slow.  They claimed the degree of 
over-reduction leading to the side product correlated with the Lewis basicity of the solvent, 
indicating that complexation of the silyloxy by some aluminium species was probably 
involved in the reaction.  It was thought that the complexation occured through a second 
equivalent of diisobutylaluminium hydride, followed by an intramolecular conjugate 
hydride displacement (Scheme 2.60) that would give the enamine, which would produce 
the side product upon work up.   
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Scheme 2.60 – Mechanism for the formation of 190 
 
The over-reduction problem had also occurred in an earlier synthesis of fragment A at the 
start of the project.  The problem had been overcome by using ether as a solvent instead of 
dichloromethane.[69]   
 
In order to stop or even reduce the amount of side product being formed, different 
variables were tested.  Table 4 shows a selection of reactions of the tests carried out. 
 
Table 4 – Test reactions carried out to reduce amount of side product 190 formed using 
DIBAL reagent supplied by Aldrich 
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Entry 
 
Solvent 
 
Temperature 
 (time left at 
temperature) 
Equivalents  
of DIBAL  
(solvent 
supplied in) 
 
Work up 
Ratio of 
product 177 
to side 
product 190 
 
Conversion 
from 
starting 
material 
1 CH2Cl2 0  °C (2 h) 2 (CH2Cl2) Silica - - 
2 CH2Cl2 0  °C (2 h) 2 (CH2Cl2) HCl (aq) - - 
3 CH2Cl2 0  °C (2 h) 2 (CH2Cl2) NH4Cl 
(aq) 
1:2 93 
4 CH2Cl2 0  °C (2 h) (Fresh bottle) 
2 (CH2Cl2) 
NH4Cl 
(aq) 
1:3 83 
5 CH2Cl2 -40  °C (2 h) 2 (CH2Cl2) NH4Cl 
(aq) 
1:3 80 
6 CH2Cl2 -40  °C (2 h) (Titrated 
DIBAL) 
2 (CH2Cl2) 
NH4Cl 
(aq) 
1:4 76 
7 CH2Cl2 0  °C (2 h) 1 (CH2Cl2) NH4Cl 
(aq) 
No reaction - 
8 Et2O -78  °C (2 h) 2 (CH2Cl2) NH4Cl 
(aq) 
No reaction - 
 
9 Et2O 0  °C (2 h) 2 (CH2Cl2) NH4Cl 
(aq) 
No reaction - 
 
10 Et2O 0  °C (2 h) 2 (Hexane) NH4Cl 
(aq) 
No reaction - 
 
11 Et2O -40  °C to 
20  °C (4 h) 
2 (CH2Cl2) NH4Cl 
(aq) 
No reaction - 
12 Et2O -40  °C to 
20  °C (16 h) 
2 (CH2Cl2) NH4Cl 
(aq) 
No reaction - 
13 THF 0  °C (2 h) 2 
(Cyclohexane) 
NH4Cl 
(aq) 
No reaction - 
14 THF 0  °C (6 h) 2 
(Cyclohexane) 
NH4Cl 
(aq) 
No reaction - 
15 (Fresh 189) THF 0  °C – 20  °C 
 (16 h) 
2 
(Cyclohexane) 
NH4Cl 
(aq) 
No reaction - 
16 Hexane 0  °C (2 h) 2 (Hexane) NH4Cl 
(aq) 
No reaction - 
17 Hexane 0  °C (2 h) 2 + 2 after 2 h 
(Hexane) 
NH4Cl 
(aq) 
No reaction - 
18 Hexane 0  °C (2 h) 2 
(Cyclohexane) 
NH4Cl 
(aq) 
No reaction - 
19 Hexane 0  °C (2 h) 2 (Hexane) NH4Cl 
(aq) 
No reaction - 
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Before actually isolating any product, the work up had to be optimised (entries 1-3).  Using 
silica gel to remove any excess diisobutylaluminium hydride was leaving a sticky 
aluminium residue.  The product might have been trapped in this sticky residue.  The work 
up was carried out using 1M aqueous hydrochloric acid, which removed any aluminium 
salts from the organic layer.  Another alternative work up was using saturated ammonium 
chloride.  This was added to the quenched reaction mixture and left to stir at 0  °C for one 
hour until the aluminium salts precipitated out.  This was preferred over the hydrochloric 
acid work up, as the salt could be seen forming and produced a cleaner crude 1H NMR 
spectrum.   
 
A fresh bottle of reagent was then used, to ensure a good quality of the reagent (entry 4), 
but the same result was obtained. 
 
The next variable to be changed was the temperature of the reaction (entries 5 and 6).  The 
nitrile was dissolved in dichloromethane and diisobutylaluminium hydride was added to 
the reaction at -40  °C, however over-reduction still occurred. 
 
As the second equivalent of diisobutylaluminium hydride was causing the over-reduction, 
the reaction was carried out using only one equivalent to see if only the product was 
obtained (entry 7).  This reaction was unsuccessful and only starting material was 
recovered. 
 
Having examined the literature paper by Reid and Debiak, we decided to run the reaction 
in diethyl ether at different temperatures (entry 8-12).  The diisobutylaluminium hydride 
was added at -40  °C and the reaction was monitored by TLC every thirty minutes; 
however, after two hours no reaction had taken place.  The reaction was left to warm to 
room temperature overnight and after work up the product and side product were still 
present.  Reactions attempted in THF at diverse temperatures also gave no product (entries 
13-15).  Ether and THF complex to the diisobutylaluminium hydride and reduces its ability 
to react with the nitrile.  We therefore decided to use non-complexing solvents for further 
attempts (entries 17-19), but once again, no reaction was observed.   
 
We then questioned the quality of the diisobutylaluminium hydride reagent.  Two test 
reactions were carried out in hexane, as this was the solvent that the diisobutylaluminium 
hydride was supplied in.  One bottle of diisobutylaluminium hydride was from Aldrich and 
the other from Fisher (Table 5).  Both were new bottles so that a fair comparison could be 
 76 
carried out.  The hexane was freshly distilled onto molecular sieves to remove any 
moisture present.  Both reactions containing the nitrile were cooled in hexane to -78 °C.  
Two equivalents of diisobutylaluminium hydride were added dropwise to the reactions, 
which were then allowed to warm to room temperature and stirred for two hours.  The 
reactions were quenched with ethyl acetate and diluted with diethyl ether.  Ammonium 
chloride was added and stirred at 0 °C for forty five minutes to remove any excess 
diisobutylaluminium hydride.  The reactions were filtered over celite and dried over 
sodium sulfate.  Once the solvent had been evaporated, the crude products were analysed.   
 
Table 5 - Test reactions carried out to reduce amount of side product 190 formed using 
DIBAL reagent supplied from Fisher 
 
 
Entry 
 
Solvent 
 
Temperature 
 (time left at 
temperature) 
 
Equivalents  
of DIBAL  
(solvent 
supplied in) 
 
Work up 
 
Ratio of 
product 
177 to side 
product 
190 
 
Conversion 
from 
starting 
material 
20 Hexane 0 °C (2 h) 2 (Hexane) 
Fresh bottle 
NH4Cl (aq) 3:1   90 
21 Hexane 0 °C (2 h) 2 (Hexane) NH4Cl (aq) No 
reaction 
  - 
22 Hexane 0 °C (2 h) 2.5 
(Hexane) 
NH4Cl (aq) No 
reaction 
- 
23 Hexane 0 °C (2 h) 2 (Hexane 
Fresh 
bottle) 
NH4Cl (aq) 3:1   93 
 
The reaction using the bottle supplied by Aldrich, which was also the diisobutylaluminium 
hydride used in all the above test reactions, had over-reduced the cyanide as it had done 
previously.  The Fisher bottle had reduced the cyanide to the desired aldehyde with only a 
small amount of side product present (entry 20).  
 
A second reduction was then carried out using the Fisher diisobutylaluminium hydride in 
hexane.  This reaction was unsuccessful and the starting material was recovered (entry 21).  
The same result was observed when using 2.5 equivalents of DIBAL (entry 22).  The 
diisobutylaluminium hydride had only been open for four days, which shows that this 
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reaction is sensitive to the reagents used and also indicates the importance of the quality of 
the diisobutylaluminium hydride.   
 
As this reaction is very sensitive, to reduce the amount of diisobutylaluminium hydride 
waste, a large scale reduction was carried out using three grams of racemic nitrile and a 
new bottle of diisobutylaluminium hydride from Fisher.  Using the same conditions as 
above the larger scale reduction was successful however, some side product was still 
formed but after purification the aldehyde was obtained in a 70% yield (entry 23).  
Racemic fragment A had been synthesised successfully. 
 
A larger scale reduction was carried out after this using approximately five grams of 
racemic nitrile however, this reaction was not as clean and once again the side product was 
present.  The largest scale that this reaction should carried out on should be no more than 
three grams in order to obtain the best results.   
 
Finally, to prevent formation of the side product, 1.4 equivalents of fresh 
diisobutylaluminium hydride were used.  This gave the desired aldehyde 177 in a 69% 
yield without any side product being formed (Scheme 2.61).  These were the best 
conditions for the reduction of the nitrile.   
 
NC OTMS OHC OTMS
189 177
DIBAL 1.4 equiv.
Hexane
0 C, 2 h
69%
 
 
Scheme 2.61 – Optimised conditions for reduction of the nitrile 
 
This reaction optimisation was very time consuming, as nitrile 189 had to be resynthesised 
several times.  As the aldehyde of fragment A was proving to be difficult to synthesise, an 
alternative route was also devised in parallel.  This would also create an enantiopure 
fragment A.  This route would start with ketone 176 which would be converted into the 
methyl enol ether, followed by a Sharpless asymmetric dihydroxylation.  The hemiacetal 
would then be hydrolysed to the corresponding aldehyde using acid.  Finally, the alcohol 
would be protected as the trimethylsilyl ether thus giving possible access to the 
enantiopure fragment A (Scheme 2.62). 
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Scheme 2.62 – Retrosynthesis of enantiopure fragment A 
 
The start of this route was based on a precedent by Martin et al[81] who were looking at 
synthesising the AB ring system of taxane diterpenes.  The group synthesised the aldehyde 
197 by converting the ketone 194 into the enol ether 195 using dimethyl 
diazomethylphosphate (DAMP) in methanol in the presence of potassium tert-butoxide 
(Scheme 2.63).   
 
 
 
Scheme 2.63 – Converting ketone 194 into the corresponding aldehyde by Martin 
 
This reaction using ketones, leads to methyl enol ethers by trapping the intermediate 
carbene with residual methanol (Scheme 2.64). 
 
 
 
Scheme 2.64 – Mechanism of DAMP 
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To convert the ketone to the methyl enol ether, the Seyferth/Gilbert reagent had to be 
synthesised.  This was done following a procedure by Maehr et al[82] and was chosen due to 
its one-pot procedure (Scheme 2.65). 
MeO
P
OO
MeO
MeO
P
O
MeO H
N2
1. NaN3, CH3SO2Cl
rt, 15h
3. 0 C, Cs2CO3, 1 h
2. , 0 C
 
Scheme 2.65 – Preparation of Seyferth/Gilbert reagent 
 
Once the reagent had been synthesised, it was used in a test reaction with cyclohexanone.  
The first test reaction was carried out using the conditions in the Martin paper using 
cyclohexanone, dimethyl diazomethylphosphonate (DAMP), potassium-tert-butoxide and 
methanol.  The 1H NMR spectrum showed that the reaction had been somewhat successful 
with approximately 50% conversion to the desired product.  Whilst looking into this new 
approach, another paper was found where Ohira[83] had tested the dimethyl 
diazomethylphosphonate reagent on cyclohexanone using slightly different conditions to 
Martin.  A second test reaction was carried out using the conditions in the Ohira paper, 
which used potassium carbonate instead of potassium-tert-butoxide as the base (Scheme 
2.66).  1H NMR spectrum showed an approximate 50% conversion for this reaction as 
well.   
 
 
Scheme 2.66 – Test reactions using Martin and Ohira conditions 
 
The reaction was then carried out with ketone 176 using Ohira’s conditions (Scheme 2.67).  
The crude 1H NMR spectrum showed that the product was decomposing.  The reaction was 
repeated, this time using cesium carbonate as the base but again the crude 1H NMR 
spectrum showed decomposition. 
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Scheme 2.67 – Attempted conversion of the ketone to the methyl enol ether 
 
This route to synthesise the enantiopure fragment A using the Gilbert/Seyferth reagent was 
not worth continuing with so we pursued the synthesis using racemic fragment A which 
would be used in the subsequent Shapiro coupling. 
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Chapter III  
 
Towards 7-deoxy taxol and ring-closing metathesis 
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3.1 Shapiro coupling 
 
The Shapiro reaction transforms ketones to alkenes through an intermediate hydrazone.[84]  
This reaction was utilised by Chamberlin[85] who reported a method that generated a 
variety of vinyllithium derivatives that could be trapped using an assortment of 
electrophilic reagents.  
 
The Shapiro reaction is very sensitive and previously within the group it has been difficult 
to optimise.  The key step in the reaction is the formation of the second anion (Scheme 
3.01), detected by a colour change from red (monoanion) to dark red (dianion).   
 
 
 
Scheme 3.01 – Mechanism of Shapiro reaction 
 
Test Shapiro reactions were carried out using hydrocinnamaldehyde and the C ring 
hydrazone.  tert-Butyllithium was added to a cooled solution of hydrazone in 
tetrahydrofuran, the solution turned red but doubt about the colour of the reaction led to the 
addition of two extra equivalents of tert-butyllithium (entry 1, Table 3.1).  Addition of 
excess tert-butyllithium results in the addition of t-butyl lithium to the aldehyde.   
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Table 3.1 – Test Shapiro reactions using hydrocinnamaldehyde 
 
 
Entry 
Amount of 
solvent per 
500 mg 
hydrazone 
 
Equivalents 
of tBuLi 
 
Aldehyde 
purified 
 
Reaction 
time 
 
Result 
 
1 
 
1.0 mL 
 
2.0 (+ 2.0) 
 
No 
 
30 min 
Addition of t-
butyllithium to 
aldehyde 
2 1.0 mL 2.0 No 30 min Alkene 199 
3 4.0 mL 2.0 No 30 min Alkene 199 
4 4.0 mL 2.0 No 5 h Alkene 199 
5 1.5 mL 2.15 Yes 30 min Alkene 199 
6* 1.5 mL 2.15 Yes 2 h Product 61% 
* C ring was azeotroped with toluene 
 
The reaction was repeated again, but this time only two equivalents of tert-butyllithium 
were added, hydrocinnamaldehyde was then added, however this reaction was also 
unsuccessful (see entry 2, Table 3.1). 
 
We thought any moisture present in the system might affect the reaction as this would 
promote the formation of the alkene 199, a side product formed if the vinyl anion does not 
react with the aldehyde but is instead protonated (Scheme 3.02).  This alkene has very 
distinct peaks in the 1H NMR spectrum, found at around 5.31 ppm (d) and 5.25 ppm (ddd) 
representing the two alkene protons.  This allows for the easy identification of the alkene 
product in the spectrum.     
 
 
 
Scheme 3.02 – Side product of Shapiro reaction 
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The concentration of the reaction was then varied (see entries 3 and 4, Table 3.1).  The 
reaction was also left stirring for longer to give the reagents time to react; again these 
reactions failed.   
 
The aldehyde was purified to remove any excess moisture that could affect the reaction.  
Addition of the freshly distilled aldehyde to the reaction mixture showed no reaction had 
taken place once analysed by 1H NMR.  A slight excess of tert-butyllithium (2.15 
equivalents) was added to ensure that the two deprotonations were taking place. 
 
The hydrazine was azeotroped with toluene then placed under vacuum for four hours to 
remove any moisture present.  tert-Butyllithium (2.15 equivalents)  was added to the dried 
hydrazone before the aldehyde was added at -78  °C.  After work up, the crude 1H NMR 
spectrum showed that the desired aldehyde had been formed and conversion was calculated 
using the ratio of starting material to product from the spectrum (Scheme 3.03). 
 
 
 
Scheme 3.03 – Successful test reaction with hydrocinnamaldehyde 
 
After the success of the test reaction, we carried out Shapiro reactions with fragment A 
(Scheme 3.04).  
  
 
Scheme 3.04 – Shapiro reaction using fragment A  
 
 
In all cases, the aldehyde was freshly prepared and all the starting materials were 
thoroughly dried under vacuum after azeotroping with toluene.  Different conditions were 
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investigated to see if the yield of the reaction could improve.  Some of these can be found 
in Table 3.2. 
 
Table 3.2 – Results of early Shapiro reactions carried out 
 
 
Entry 
Equivalents 
of 
hydrazone 
in THF 
(mL) 
 
Equivalents 
of tBuLi 
 
Equivalents 
of CeCl3  
 
Reaction 
time at  
-78  °C 
 
Yield of 
mixture after 
removal of 
199  
1 1.5 (4 mL) 3.0 - 5 h - 
2 1.2 (1.5 mL) 2.1 - 2 h - 
3 1.2 (1.5 mL) 2.1 1.2 2 h 13% 
4 1.2 (1.5 mL) 2.1 1.2 30 min 24% 
5 1.1 (1.5 mL) 2.1 1.2 30 min - 
6 1.1 (2 mL) 2.1 1.2 30 min 21% 
7 1.1 (3 mL) 2.1 1.2 30 min 33% 
8 1.2 (3 mL) 2.1 1.2 30 min 24% 
9 1.2 (3 mL) 2.1 1.2 1 h 19% 
10 1.2 (3 mL) 2.15 1.2 1 h 20% 
11 1.2 (3 mL) 2.15 1.2 30 min 29% 
12 1.2 (6 mL) 2.15 1.2 30 min 35% 
13 1.2 (6 mL) 2.15 1.3 30 min 30% 
14 1.2 (3 mL) 2.15 1.3 30 min 23% 
15 1.2 (4 mL) 2.15 1.3 30 min 17% 
16 1.2 (4.5 mL) 2.15 1.3 30 min - 
17 1.2 (5 mL) 2.15 1.2 1 h 45% 
 
The first few attempts at the Shapiro reaction were carried out without any cerium 
trichloride (entries 1, 2) as test reactions.  Previous work in the group[71a] had shown that   
in order to increase the yield of the reaction, it was necessary to increase the 
nucleophilicity of the vinyl anion by transmetallating it with cerium trichloride (Scheme 
3.05). 
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Additive Time after addition Yield  
None - 20% 
CeCl3 30 min 85% 
 
Scheme 3.05 – Improved yield by addition of CeCl3 (Cong Ma) 
 
Anhydrous cerium trichloride was dried using a literature procedure[74] and tetrahydrofuran 
was added.  The cerium trichloride was stirred vigorously in tetrahydrofuran, between two 
and four hours, to create a suspension.  The suspension was cooled to -78  °C and titrated 
with tert-butyllithium to give a yellow coloured solution.  This was then added via cannula 
to the dianion (Scheme 3.06). 
 
NNHTris
OTr
OTr
OH
OTMS
OHC OTMS
tBuLi, CeCl3
THF, -78°C
13 - 45%
156 177
201
 
 
Scheme 3.06 – Shapiro reaction with CeCl3 
 
The cerium trichloride used was in anhydrous bead form.  These were supplied in a vial 
with an inert atmosphere and were weighed into the reaction flask under argon before the 
flask was sealed, under an inert atmosphere, and then weighed.  Tetrahydrofuran was then 
added to the beads and they were stirred vigourously for two hours under argon before 
being titrated with tert-butyllithium.  At first the beads were not thought to be crushed 
enough to create a good enough suspension and so they were left stirring vigorously for 
four hours.  The reactions using the anhydrous cerium trichloride beads were not producing 
the desired diastereomers in good yields, and so after being weighed they were placed 
under vacuum to remove any moisture that might have been present.  The solvent was then 
added and the solution was stirred vigourously (entries 3-9).   
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Depsite best efforts, the yields were still low and so we switched to using the cheaper 
powdered version, cerium trichloride heptahydrate (entries 11-17).  This was dried by 
heating under vacuum for set time periods and then heating under vacuum overnight.  This 
was then cooled, tetrahydrofuran was added and the powder was stirred vigourously for 
four hours before being titrated with tert-butyllithium.  The yields improved slightly but 
not enough to ensure that a moderate to good yield was being obtained.  Adding more 
equivalents of cerium trichloride was thought to improve the nucleophilicity of the vinyl 
anion, but this could also have led to more moisture being present in the system and more 
tert-butyllithium added to titrate it with.  Both factors could have been affecting the 
reaction. 
 
Despite transmetallation of the vinyl anion, the yield of the Shapiro reaction still remained 
low.  The maximum yield of the two diastereomers formed was 45%, with the alkene being 
obtained as the major product in 50% yield relative to the aldehyde.   
 
Titrating the cerium trichloride with tert-butyllithium should remove any water present.  
However, a literature procedure was discovered where two equivalents of lithium chloride 
were added to the cerium trichloride.[86]  This promoted the addition of more hindered 
nucleophiles and claimed to minimise any side reactions occurring (Scheme 3.07). 
 
 
 
Scheme 3.07 – Use of LiCl to improve reaction yields by Knochel 
 
Two equivalents of lithium chloride were added to the cerium trichloride, which was 
heated and stirred under vacuum overnight.  Addition of the lithium chloride allows the 
normally insoluble cerium trichloride to dissolve.  When this suspension was added to the 
dianion the solution turned black and after work up the crude 1H NMR spectrum showed a 
number of signals.     
 
Adding more solvent or reagent could increase the amount of moisture in the system 
(entries 4-14).  The aldehyde 177 and hydrazone 158 were both azeotroped with toluene 
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and dried under vacuum before being added to the reaction.  At first only for one hour but 
this was extended up to eight hours.  In order to reduce the amount of moisture in the 
solvent molecular sieves were added and left for at least two to four hours under an inert 
atmosphere.  As well as using solvent from a departmental still, freshly distilled solvent 
from the laboratory was used, but again this led to no improvement in the yield of the 
reaction.    
 
Another factor that could have affected the reaction is the freshness of the aldehyde.  The 
first few times the reaction was carried out the aldehyde had been in the fridge, where 
again it could have collected moisture or even start to degrade (entries 1-3).  Before the 
aldehyde was used it was analysed for any signs of degradation using 1H NMR.  The issues 
with synthesising the aldehyde and the hydrazone at first meant that both were not as fresh 
as could be.  More starting material was brought forward to see if the freshly synthesised 
hydrazone and aldehyde would help to increase the yield of the reaction (entries 4-18).  
This did not seem to have any effect on the reaction and low yields of the two 
diastereomers continued to be isolated.   
 
At first the reaction was carried out quite concentrated as it is thought that the reaction is 
sensitive.  This was affecting the yield of the reaction and so using a different procedure 
[71a]
 was followed, this time carrying out the reaction in a more diluted concentration.  This 
did improve the separation and work up, as well as visualising the colour change of the 
hydrazone once adding the tert-butyllithium, but the reaction yields were still low despite 
following a procedure that claimed an 80% yield.   
 
By varying the number of equivalents of hydrazine and tert-butyl lithium used it was 
thought that this would allow the aldehyde to react with an increased percentage of the 
vinyl anion.  The negative impact by doing this is that with more hydrazone present there 
is an increased risk that more undesired alkene 199 will be formed.   
 
The tert-butyllithium was titrated before every experiment (entries 1-18) in order to obtain 
its concentration.  As with the diisobutyllithium before, older bottles could possibly have 
affected the reaction with the increase in solids forming in the bottle.  The older bottles 
may also have affected the rate of the deprotonation of the hydrazone, despite allowing 
extra volume for a decrease in its concentration.  This could lead to over or reduced 
addition of the reagent and therefore affect the formation of the vinyl anion.   
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The number of equivalents of aldehyde was varied from 1 to 1.2; this was seen not to have 
reacted with the vinyl anion by TLC after work up.  Most of the unreacted aldehyde could 
not be recovered as its rf value was very similar to that of the alkene 199 and the two 
products came off the column together, even though attempts at separating them off with 
specific eluents were carried out.   
 
The first procedure we were following[71b] left the reaction stirring for five hours, whereas 
the second procedure said for thirty minutes.[71a]  The time the reagents had to react could 
have affected the result, most likely in our case it did not, as the alkene had already formed 
thus reducing the amount of vinyl anion the aldehyde could react with.  We varied the time 
of the reaction to see if we could get close to the yields acquired in the two procedures, 
however we were not successful.   
 
After the coupling experiments the crude mixture was purified.  The TLC plate of the 
crude mixture showed up to six or seven spots.  The three nearest the top of the plate were 
the undesired alkene 199, unreacted aldehyde and an unknown fraction.  These were easily 
removed together, but were never separated individually.  The two inseparable 
diastereomers were the next fraction to come off, followed by three other unknown 
compounds.  The number of spots present on the TLC plate showed that this reaction is not 
clean and that side reactions are occurring and are affecting the yield of the reaction. 
 
At this point where it seemed like we were making progress we ran out of material and 
more had to be brought through.  We continued carrying out Shapiro reactions with the 
conditions in Scheme 3.06 despite the low yields and formation of the unwanted alkene 
199, but this could be removed by flash column chromatography leaving the two 
diastereomers.    
 
The mixture of diastereomers was then dissolved in tetrahydrofuran and subjected to mild 
acidic conditions to remove the protecting trimethylsilyl group.  Separation by flash 
column chromatography gave the two trans diols 178a and 178b (Scheme 3.08).   
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Scheme 3.08 - Separation of the two diastereomers 
 
Danishefsky[87] was the first to study the diastereoselectivity of the addition of nucleophiles 
to aldehydes at the C2 position in order to obtain the C1-C2 diol of taxol.  When adding a 
siloxy aldehyde to a lithiated styrene, the trans diol was obtained, in a 1:2 ratio, with the 
cis diol.  Reacting an α-hydroxy aldehyde with the lithiated styrene gave the trans diol 
exclusively.  This was due to chelation of the lithium by the two oxygens of the substrate 
(Scheme 3.09). 
 
 
 
Scheme 3.09 – Trans diol formation by Danishefsky[87] using lithium chelation 
 
The cis 1,2-diol can be obtained through a transition state following the polar Felkin-Ahn 
model.  The siloxy group is orthogonal to the carbonyl group in the transition state; this 
lowers the energy of the lowest unoccupied molecular orbital of the π system rendering it 
more reactive.  The overlap between σ* C-OSi is π* C=O are at maximum when in this 
conformation (Figure 3.01). 
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Figure 3.01 – Lowering of energy of the LUMO    
 
To obtain the trans diol the Cram-chelate could be involved, as there could be 
complexation between the siloxy group and the carbonyl group, but this is unlikely.  Both 
transitions are shown below in Scheme 3.10. 
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Scheme 3.10 – Selectivity models 
 
Another possibility is that the trans product can be obtained via the steric Felkin transition 
state, where the largest group, in this case the chain, which contains the gem-dimethyl 
group, is positioned perpendicularly to the aldehyde.  This would give the more stable 
conformer that the nucleophile can attack giving the trans product (Scheme 3.11).  
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Scheme 3.11 – Steric Felkin model giving the trans product 
 
With the two trans diols separated, the corresponding metathesis precursors could be 
synthesised.   
 
 
3.2 Synthesis of Metathesis Precursors 
 
Both diastereomers had the trityl protecting group removed under acidic conditions using 
Amberlyst H-15 (Scheme 3.12) giving triols 204a and 204b in moderate to good yields. 
 
 
 
Scheme 3.12 – Removal of the trityl group 
 
The next step was to transform the primary hydroxyl group to the terminal olefin.  This had 
previously been done using Grieco’s method.[88] Both triols were subjected to Grieco’s 
conditions however following work up the desired product was not obtained (Scheme 
3.13).   
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Scheme 3.13 – Attempt at Grieco reaction 
 
The crude 1H NMR spectrum showed that two sets of aryl peaks were present.  One from 
the excess o-nitrophenylselenocyanate and the other from the selenium ether formed in the 
first step of the reaction (Scheme 3.14). 
 
 
 
Scheme 3.14 – Selenium ether obtained from Grieco reaction 
 
The Grieco elimination is carried out in two steps; the first forms a selenium ether.  The 
alcohol reacts with o-nitrophenylselenocyanate and tributylphosphine to form a selenide in 
a nucleophilic substitution on the electron deficient selenium.  In the second step the 
selenide is oxidised, using hydrogen peroxide, to the selenoxide followed by its elimination 
(Scheme 3.15).    
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Scheme 3.15 – Grieco olefination mechanism 
 
In our case, elimination of the selenoxide had not occurred.  We had planned to add only 
hydrogen peroxide to the intermediate selenyl ether; however previous work[71a] on a 
model system, with a butyl side chain, had shown that this could lead to the epoxidation of 
the double bond between C3 and C4 (Scheme 3.16).  To avoid epoxidation, a premixed 
solution of ammonium molybdate and hydrogen peroxide was added to the selenyl ether. 
   
 
 
Scheme 3.16 – Previous work on the Grieco reaction 
 
The selenyl ether was subjected to the solution containing hydrogen peroxide and 
ammonium molybdate; however no reaction occured. 
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We then investigated a different route to prepare the terminal alkene.  Variations of the 
Appel reaction using iodine, imidazole and triphenylphosphine are an effective way to 
transform an alcohol into the corresponding alkyl iodide.  These conditions are mild and 
effective as shown by examples in the literature.  One example of this was carried out by 
Fall whilst synthesising vitamin D intermediates (Scheme 3.17).[89]  
 
 
 
Scheme 3.17 – Iodination of an alcohol by Fall 
 
Our new strategy was to perform this same variation of the Appel reaction to form the 
alkyl iodide before an elimination reaction, using sodium hydride, would give the alkene 
(Scheme 3.18). 
 
 
 
Scheme 3.18 – Planned Appel reaction route to triene 
 
Preparation of the iodide was not as successful as we had hoped for.  On addition of the 
iodine to triols 204a and 204b, the brown solution turned clear indicating some form of 
reaction; however the product was only obtained in 9% yield after work up (Scheme 3.19).  
The low yield was most likely obtained as the iodine could have reacted with the alkene in 
the starting material.     
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Scheme 3.19 – Appel reaction 
      
Despite the low yield we wanted to test the elimination reaction and so the small amount of 
taxol-like iodide product 209b was subjected to sodium hydride (Scheme 3.20).  However, 
the small scale of the reaction made it difficult to distinguish if any product had formed.   
 
 
 
Scheme 3.20 – Attempt at obtaining trienic compound 
 
Despite attempting the reaction multiple times, the yield of the alkyl iodide obtained was 
never greater than 9%.  Another method was then proposed to form the desired trienic 
compound, which would involve transforming the primary alcohol into a tosylate followed 
by elimination (Scheme 3.21).  
 
 
 
Scheme 3.21 – Proposed method to form trienic compound 
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The conditions for this reaction were found in a procedure by Nishiyama[90] who carried 
out tosylation of a primary alcohol in the presence of secondary alcohols which were 
unaffected (Scheme 3.22). 
 
 
 
Scheme 3.22 – Nishiyama tosylation 
 
The non taxol-like triol 204a was dissolved in pyridine and recrystallised tosyl chloride 
was added.  After work up, the crude 1H NMR spectrum showed fewer proton signals than 
expected and showed that the desired product had not been formed (Scheme 3.23).   
 
 
 
Scheme 3.23 – Failed attempt at tosylation 
 
The product that had been formed during the reaction was a seven-membered cyclic ether 
(Scheme 3.24).   
 
 
 
Scheme 3.24 – Seven membered cyclic ether 
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As none of the attempts at synthesising the trienic compound were successful, we decided 
to go back an earlier stage of the synthesis regarding the diol and protect it as a carbonate 
in order to synthesise the metathesis precursor (Scheme 3.25). 
 
 
 
Scheme 3.25 – New procedure towards metathesis precursors 
 
Diols 178a and 178b were subjected to carbonyl diimadazole and sodium hydride.  After 
stirring at room temperature for thirty minutes and following work up, carbonates 213a and 
213b were obtained in good yields (Scheme 3.26). 
 
 
 
Scheme 3.26 – Protection of the diol using carbonate ester 
 
Both carbonates were subjected to Amberlyst H-15 and stirred overnight at room 
temperature.  The resulting alcohols 213a and 213b were obtained in good to excellent 
yields (Scheme 3.27). 
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Scheme 3.27 – Removal of the trityl ether 
 
The alcohols 214a and 214b were then subjected to the Grieco reaction which was carried 
out in two stages as before.  The trienic compounds were obtained in good yields (Scheme 
3.28) 
 
 
 
Scheme 3.28 – Trienic compounds 
 
The two trienic compounds had already been used as metathesis precursors by Dr Cong 
Ma, so we investigated transforming these compounds into the benzoate esters before ring-
closing metathesis to evaluate the influence of the diol protecting group on the outcome of 
the metathesis reaction.  The two compounds were subjected to nine equivalents of 
phenyllithium once dissolved in tetrahydrofuran.  After stirring for one and a half hours at -
78  °C the reaction was quenched and following work up gave the desired benzoate 
(Scheme 3.29). 
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Scheme 3.29 – Transformation of carbonates to benzoate esters 
 
The benzoate esters were then subjected to ring-closing metathesis using Grubbs’ second-
generation catalyst.     
 
The undesired isomer 215a was dissolved in toluene and Grubbs’ second-generation 
catalyst was added.  After monitoring by TLC and stirring overnight, analysis of the crude 
product by 1H NMR showed that it had degraded (Scheme 3.30).   
 
 
 
Scheme 3.30 – Degradation of non taxol-like isomer 
 
The taxol-like isomer 215b was dissolved in toluene and Grubbs’ second-generation 
catalyst was added and after monitoring the reaction for one hour, TLC showed complete 
conversion of the starting material.  Purification of the crude product gave the isotaxane 
216 containing the benzoate ester in a moderate yield (Scheme 3.31). 
 
 
 
Scheme 3.31 – Formation of the isotaxane 216 
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These results are consistent with the model studies carried out previously in the group.  
Despite ene-ene metathesis normally occurring more easily than ene-yne metathesis,[91] in 
this case it was disfavoured because of the steric hinderance of the olefin at C11 due to the 
neighbouring gem-dimethyl group.   
 
In order to avoid the ene-yne metathesis we planned to unmask the ketone using a gold 
hydration reaction (Scheme 3.32). 
 
 
 
Scheme 3.32 – Planned route to avoid ene-yne metathesis 
 
Carbonyls can be synthesised by the addition of water to alkynes.  Hydration of alkynes 
has been known since 1881, when Kucherov[92] discovered that using mercury (II) salts 
under mild conditions could catalyse the hydration of alkynes.  This reaction is however 
unsuitable for modern methods due to the toxicity of mercury-based compounds and 
alternative catalysts have since been discovered.[93] 
 
In 1976, the catalytic hydration of alkynes using gold (III) catalysts was observed by 
Norman.[94]  Reactions had previously been carried out in the presence of a mercury 
catalyst but using a gold (III) catalyst significantly improved the yields (Scheme 3.33).   
 
 
 
Scheme 3.33 – Catalytic hydration of alkynes[94] 
 
Gold (I) catalysts are not sensitive to water or air and were reported as being powerful 
catalysts that could be used to promote the hydration of alkynes.[95]  Krause used a gold (I) 
catalyst to promote an intramolecular version of this reaction[96] (Scheme 3.34). 
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Scheme 3.34 – Intramolecular hydration of an alkyne by Krause 
 
Our metathesis precursor has a similar structure to that used by Krause in relation to the 
position of the alkyne and the alcohol, which may result in the formation of the hemi acetal 
if the tertiary alcohol is unprotected. 
 
However, we still possessed some carbonate 179b and decided to subject this to the 
hydration conditions as a comparison.  The alcohol that would attack the gold-coordinated 
alkyne is now protected and we thought that the alkyne would be transformed to give the 
ketone (Scheme 3.35). 
 
O O O OO
PPh3AuCl 5 mol%
AgSbF6 10 mol%
MeOH, rt
O O
179b
H2O
 
 
Scheme 3.35 – Planned unmasking of the alkyne from the carbonate 
 
The carbonate 179b was dissolved in methanol and the gold (I) catalyst was added along 
with two drops of water.  After work up and separation of the catalyst, starting material 
was recovered.  The reaction had not worked as the gold (I) catalyst is not active enough 
on its own.  The reaction was repeated with the addition of 10 mol% silver (I) 
hexafluoroantimonate to activate the catalyst by forming an active cationic gold species.  
After stirring at room temperature for thirty minutes the reaction was quenched.  The 
resulting product was not what we had been expecting (Scheme 3.36). 
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PPh3AuCl 5 mol%
AgSbF6 10 mol%
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O O
179b 221
40%
 
 
Scheme 3.36 – Product formed after hydration of carbonate 
 
The resulting structure of 221 was tentatively assigned using both 1H and 13C NMR 
techniques.  When comparing the 1H NMR spectrum of 221 with the starting material 
179b, peaks in the region 5.0 ppm to 6.2 ppm had significantly changed (Figure 
3.02).
 
 
Figure 3.02 – Comparison of 1H NMR spectra for compounds 179b and 221 
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H-10 and H-1’ are almost unaffected, and H-2 and H-4 only have a slight difference in 
their chemical shifts.  However, H-11 and H-2’ are have completely different aspect and 
chemical shifts.   
 
Another difference between the spectra of compounds 221 and 179b was regarding the 
protons at C14.  The 1H NMR spectrum of 179b shows the C14 protons coupled to the 
methyl group of either C16 or C17, resulting in two doublets of quartets.  However; the 
peaks found in the 1H NMR spectrum of 221 appear to be a doublet and a broad doublet 
(Figure 3.03).   
 
 
 
Figure 3.03 – C14 peaks from the 1H NMR spectra of compounds 179b and 221 
 
The COSY spectrum showed that the peaks found at 6.15 ppm, 5.60 ppm and 1.74 ppm all 
coupled together and had broad signals.  We thought these peaks represented protons H-11, 
H-2’ and H-18 respectively.  The peak at 5.40 ppm was coupled with peaks found at 2.65 
ppm and 1.74 ppm, which could respresent protons H-13, H-14 and H-18 respectively.  
The two protons found at 2.75 ppm and 2.65 ppm were also coupled together, 
respresenting the two protons at H-14.  13C NMR (13C, DEPT and HSQC) analysis 
confirmed the possible structure of 221 containing a seven-membered ring.  Mass 
spectrometry showed that compounds 179b and 221 have the same mass showing a 
rearrangement of atoms has taken place.    
 
The mechanism for the formation of the seven-membered ring is simple compared to some 
other gold cyclisation pathways.  The gold (I) catalyst coordinates to the alkyne, followed 
by the attack of the alkene.  The seven-membered ring is formed and 
deprotonation/protodeauration leads to the product (Scheme 3.37). 
221 179b 
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Scheme 3.37 – Formation of seven-membered ring 
 
The taxol-like metathesis precursor 215b was then dissolved in methanol and the gold (I) 
catalyst was added.  The resulting product was a mixture of diastereomers of hemiacetal 
222 (Scheme 3.38). 
 
 
 
Scheme 3.38 - Formation of the hemiacetal 
 
A mechanism suggested by Krause[96] can be used to explain the formation of the 
hemiacetal (Scheme 3.39).  The gold catalyst coordinates to the alkyne; this is followed by 
nucleophilic attack of the oxygen to form the cyclic gold complex.  Protodemetallation 
then occurs and releases the gold catalyst back into the cycle.  Nucleophilic attack by the 
methanol and loss of a proton then affords the product. 
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Scheme 3.39 – Formation of the hemiacetal as suggested by Krause 
 
The two diasteromers 222 were then subjected to a ring-closing metathesis reaction to see 
if the BC bicycle could be closed avoiding ene-yne metathesis.  Due to the small scale of 
the reaction, it was hard to tell if the BC bicycle had been formed.  The 1H NMR spectrum 
was also hard to analyse due to the presence of the two diasteromers.  Due to time 
constraints we were not able to repeat this reaction on a larger scale. 
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3.3 Synthesis of enantiopure fragment A 
 
We wanted to improve the yield of the Shapiro reaction and form only the taxol-like 
isomer.  This would be obtained by synthesising an enantiopure version of fragment A.  
 
There are several methods reported in the literature for the enantioselective cyanation of 
ketones.  The first was discovered by Sugai who carried out an enzymatic hydrolysis of a 
racemic α-acetoxy nitrile using the microorganism Pichia miso IAM 4682.  The 
microorganism isolates the non-hydrolysed enantiomer in its enantioenriched form[97] 
(Scheme 3.40).   
 
 
 
Scheme 3.40 – Sugai enzymatic enantioselective cyanation 
 
Similarly, Effenberger[98] and co-workers discovered that using (R)- and (S)-oxynitrilases, 
isolated from rubber trees, could also directly catalyse the enantioselective cyanation of 
aldehydes and ketones.  This reaction was limited by its scale and its poor conversion rates 
(Scheme 3.41). 
 
 
 
Scheme 3.41 – Effenberger enzymatic enantioselective cyanation 
 
Methods using titanium catalysts have also been effective.  One example involved a 
tetradentate ligand, salen, which was developed by Timofeeva.[99]  In the presence of this 
catalyst, aromatic ketones could be transformed to siloxy cyanohydrins, with good 
enantiomeric excesses (Scheme 3.42). 
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Scheme 3.42 – Enantioselective cyanation using titanium catalyst salen 
 
Lewis bases have also been used to catalyse the cyanation reaction.  Deng and co-
workers[100] performed an enantioselective cyanation with tertiary chiral amines using a 
ligand developed by Sharpless.[101]  Using either the DHQD or DHQ derived ligand, (R)- or 
(S)- cyanohydrins were produced in excellent enantiomeric excesses (Scheme 3.43).  
Cyanation of α-dialyoxy ketones could also be performed using trimethylsilyl cyanide 
instead of ethyl cyanoformate.[102]     
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Scheme 3.43 – Enantioselective cyanation using chiral amines 
 
Deng[103] proposed a mechanism for the reaction involving kinetic resolution to explain the 
enantioselectivity of the different substrates (Scheme 3.44).  The kinetic resolution step is 
the final formation of the carbonates.  If the rate of interconversion is slower than that of 
the kinetic resolution step, the enantiomeric excess decreases.  α-Dialkoxy ketones are 
attacked more easily due to the effects of the electron-withdrawing group, which therefore 
increases the rate of interconversion.  High enantiomeric excesses are obtained when using 
α-dialkoxy ketones in cyanation reactions.   
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Scheme 3.44 – Proposed mechanism of the enantioselective cyanation by chiral amines 
 
We decided to use Deng’s method for the cyanation of our highly sterically hindered 
ketone as it seemed efficient and the catalyst could be purchased directly from a chemical 
supplier.   
 
Ketone 176 was subjected to a reaction with 20 mol% of (DHQ)2AQN and ethyl 
cyanoformate.  After seven days standing in the freezer at -20  °C, the desired non racemic 
cyanohydrin was obtained in a 30% yield.  A second reaction was carried out, this time 
adding 30 mol% of the catalyst, and after work up gave the desired cyanhydrin in a 54% 
yield (Scheme 3.45). 
 
O NC OH
(DHQ)2AQN
CHCl3, CNCOOEt
-20 °C, 7 days
54%176 227
[]22 D: +29.1
 
 
Scheme 3.45 – Enantioselective cyanation of ketone 176 
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The specific rotation was calculated as +29.1 (c 1.2, CH2Cl2) for compound 227.  This 
reaction had been carried out previously in the group on 176 but using the ligand 
(DHQD)2AQN, producing the undesired enantiomer.  The specific rotation for the 
enantiomer was -74.1 (c 1.7, CH2Cl2) and the ee was determined to be 99% by chiral 
HPLC.  This result proves that we have synthesised the desired enantiomer of 227, 
however the lower specific rotation could mean either that the compound is not 
enantiopure or that there are traces of the chiral catalyst present.  Chiral HPLC will need to 
be carried out on compound 227 to determine its enantiopurity.   
 
If time had allowed the enantiopure cyanohydrin would have been subjected to a reduction 
using diisobutylaluminium hydride, followed by the alcohol being protected with a 
trimethylsilyl ether to avoid polymerisation that could occur as seen in the previous 
work.[71a]  This enantiopure fragment A would have then been used in a Shapiro reaction to 
give only the taxol-like isomer (Scheme 3.46). 
 
 
 
 
Scheme 3.46 – Future work on enantiopure fragment A 
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4.1 Conclusions and future work 
 
4.1.1 Conclusions 
 
Fragment A has been synthesised and the reproducibility and conditions of the nitrile 
reduction have been studied in detail (Scheme 4.01).   
 
Br
Zn, NH4Cl (aq),
THF, 1 hCH2Cl2, 1.5 h OHO
H DMP
CH2Cl2, 2 h
O
DMP
OH
Yield over 2 
steps 70%
90%
TMSCN, CH2Cl2
ZnI2, rt, 2 h OTMSNC
99%
OTMSOHC
DIBAL (Fisher),
 Hexane
-78°C, 0 °C,  2h
69%
187 188
176 189 177
 
 
Scheme 4.01 – Synthesis of fragment A 
 
The start of a synthesis of enantiopure fragment A has been carried out and the end 
synthesis planned (Scheme 4.02). 
 
 
 
Scheme 4.02 – Beginning of enantiopure synthesis of fragment A 
 
Optimisation of the Shapiro reaction has been carried out despite being time consuming 
only led to moderate yield of the desired products.  An isotaxane has been synthesised with 
the benzoate ester precursor (Scheme 4.03).  Isotaxanes are precursor to analogues of taxol 
not available by semi synthesis, which might exhibit interesting biological activities.   
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Scheme 4.03 – Synthesis of an isotaxane 
 
The ketone at C12 was unmasked using a gold hydration reaction attempts using the 
carbonate precursor led to the formation of a seven memebered ring, whilst the benzoate 
precursor formed the hemiketal, (Scheme 4.04). 
 
 
 
Scheme 4.04 – Hydration reactions and products 
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4.1.2 Future work  
 
The Shapiro coupling has caused a number of problems, with time and resources wasted.  
To move forward either the two reactants must be modified or a new coupling procedure 
must be attempted.  Depsite following a published procedure, the results cannot be 
repeated and this has affected our planned synthesis.   
 
If the enantiopure fragment A is synthesised successfully, this would be coupled with the 
hydrazone using the Shapiro reaction, however with previous problems this reaction had 
caused, a new route could be planned.   
 
 
 
Scheme 4.05 – Enantiopure fragment A completion and coupling 
 
Following work performed by Schiltz in the group,69 the C ring ketone 146 could be 
transformed into the vinyl bromide so that a tin-bromide exchange could take place 
(Scheme 4.06). 
 
O
OTr
146
TfO
OTr
Me3Sn
OTr
PhNTf2, KHMDS
HMPA
(Me3Sn)2, Pd(PPh3)4
LiCl
147 148
Br
OTr
149
Br2
 
Scheme 4.06 – Transformation of the 146 to the vinyl bromide 149 
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The vinyl bromide would then undergo a halogen-lithium exchange, followed by a 
coupling reaction with fragment A 177, as previously carried out by Schiltz with aldehyde 
144.  The sterics of the alkyne group might affect the reaction, but it would be worth 
attempting to see if an improved yield could be obtained (Scheme 4.07). 
 
Br
OTr
149
OTr
OH OTMS
HCl 1N
178a 178b
tBuLi
taxol-like
TMSO CHO
OTr
OH OH
OTr
OH OH
177
 
 
Scheme 4.07 – Coupling of the vinyl bromide 149 and aldehyde 177 
 
RCM reactions need to be carried out on the hemiketal benzoate ester; this could then be 
followed by a Sharpless asymmetric dihydroxylation and selective protection of one 
alcohol.  Oxidation of the remaining alcohol to the ketone which would then be used to 
perform a pinacol coupling, however the hemiketal will need to be opened for this be to 
achieved.   
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Scheme 4.06 – Work towards taxol 
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Chapter IV 
 
Experimental Details 
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General Experimental 
 
NMR 
NMR spectra were recorded on a Bruker 400 MHz Spectrospin spectrometer (1H NMR at 
400 MHz and 13C NMR at 400 MHz or 500 MHz).  Chemical shifts are reported in ppm.  
1H NMR spectra were recorded with CDCl3 as solvent using (δ = 7.26) as internal 
standard, and for 13C NMR spectra, the chemical shifts are reported relative to the central 
resonance of CDCl3 (δ = 77.16).  Signals in NMR spectra are described as singlet (s), 
doublet (d), triplet (t), quartet (q), quintet (quint), sextet (sext), septet (sept), multiplet (m), 
broad (b) or combination of these, which refers to the spin-spin coupling pattern observed.  
DEPT 135, DEPT 90 and two-dimensional (COSY, HSQC) NMR spectroscopy were used 
where appropriate to assist the assignment of signals in the 1H and 13C NMR spectra.  
Taxol numbering used for NMR assignment.   
 
IR and Mass Spectrometry 
Infrared spectra were obtained neat using a SHIMADZU spectrometer.  High resolution 
mass spectra were recorded under EI, FAB, CI and ES conditions by the analytical services 
at the University of Glasgow.  Elemental analyses were carried out on an Exeter Analytical 
Elemental Analyser EA 440.   
 
Chromatography 
Column chromatography was performed under pressure using Fisher matrix silica 
60. Macherey-Nagel aluminium-backed plates pre-coated with silica gel 60 (UV254) were 
used for thin layer chromatography and were visualised using UV light or by staining with 
potassium permanganate (3 g of potassium permanganate, 20 g potassium carbonate, 5 mL 
5% aqueous sodium hydroxide and 300 mL water) or a acidic ethanolic anisaldehyde 
solution (formed by dissolving 15 g of anisaldehyde in 250 mL ethanol and 2.5 mL conc. 
sulfuric acid). 
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Solvents and Reagents  
Liquid reagents were distilled prior to use if needed. All reagents were purchased from 
commercial suppliers and used without further purification unless otherwise stated. 
 
General Reaction Conditions  
Reactions involving air-sensitive agents and dry solvents were performed in glassware 
dried in an oven 120 °C or flame dried prior to use. These reactions were carried out with 
the exclusion of air using an argon atmosphere.  Brine refers to a saturated solution of 
sodium chloride in distilled water. 
 
Nomenclature 
IUPAC nomenclature was used for all compounds (determined by reaxys). 
NMR spectra descriptions are numbered using a chain extension or numbering used for 
Taxol. 
 
Known compounds have already been fully characterised.[71a]  
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Preparation of 2-Iodoxybenzoic acid (IBX).[104]  
 
 
 
2-Iodobenzoic acid (30.0 g, 121 mmol) was added to a solution of oxone (144.8 g, 235.5 
mmol, 2.0 equiv) in deionised water (500 mL) in a 1 L flask.  The reaction mixture was 
warmed to 73  °C over 20 min and was stirred for 3 h.  The suspension was then cooled 
between 0-5  °C and stirred for 1.5 h.  The white powder was filtered through a sintered 
glass funnel and washed with deionised water (4x100 mL) and acetone (2x100 mL) before 
being left to dry at room temperature for 16 h (no inert atmosphere necessary).  The 
product was obtained as a white solid (29.6 g, 88%).   
  
 
Preparation of Dess-Martin Periodinane (DMP).[105] 
 
 
 
2-Iodoxybenzoic acid (29.5 g, 105 mmol) was added to a solution of p-toluenesulfonic acid 
(0.16 g) in acetic anhydride (120 mL).  This was stirred at 80  °C for 2 h before the mixture 
was cooled in an ice/water bath.  The cold mixture was filtered through a sintered glass 
funnel and rinsed with anhydrous ether (250 mL). The resulting white solid was transferred 
to an argon flushed round bottom flask and stored in the freezer.  The product was obtained 
as a white solid (38.4 g, 86% yield).  
 
Problems with the DMP reagent can occur if it is not washed with enough ether.  If IBX 
residues are present the reagent does not work as well.   
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Preparation of 1-Bromo-3-methyl-2-butene.[106] 
 
 
 
First attempt 
 
2-Methyl-3-buten-2-ol (20.0 g, 232 mmol) was cooled to 0  °C in a round bottom flask.  
Hydrobromic acid (93 mL, 48% aq.) was slowly introduced into the reaction flask and the 
resulting mixture was stirred at 0  °C for 30 min.  The two layers were separated and the 
aqueous layer was extracted with dichloromethane.  The organic layers were combined and 
washed with water, brine, dried over anhydrous magnesium sulfate before being filtered 
and concentrated in vacuo (no heat in the water bath which was filled with ice water).  
Distillation of the crude product, as suggested in the method, caused the product to turn 
brown, showing signs of degradation.  This was seen in an uninterpretable 1H NMR 
spectrum.  
 
Second attempt 
 
2-Methyl-3-buten-2-ol (20.0 g, 232 mmol) was cooled to 0  °C in a round bottom flask.  
Hydrobromic acid (93 mL, 48% aq.) was added dropwise to the flask and the resulting 
mixture was stirred at 0  °C for 30 min.  The two layers were separated and the aqueous 
layer was extracted with dichloromethane.  The organic layers were combined and washed 
with water, brine, dried over anhydrous magnesium sulfate before being filtered and 
concentrated in vacuo (no heat in the water bath which was filled with ice water).  The 
crude product was obtained as a colourless oil (27.6 g, 79%). 
 
1H NMR (δH): 5.53 (tsept, 1H, J = 8.5 Hz, 1.4 Hz, H-2), 4.02 (d, 2H, J = 8.5 Hz, H-1), 1.78 
(s, 3H, Me-3), 1.73 (s, 3H, Me-3). 
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Preparation of 4-dimethylamino-N-triphenylmethyl pyridinium chloride.[107] 
 
 
 
Freshly recrystallised trityl chloride (3.00 g, 11.0 mmol, 1.10 equiv – from toluene) and 4-
dimethylaminopyridine (1.22 g, 10.0 mmol) in dichloromethane (30 mL) were stirred for 
30 min at room temperature.  Addition of diethyl ether (100 mL) precipitated the product 
which was filtered and washed with more diethyl ether.  The white solid was dried under 
vacuum for 2 h.  The product was obtained as a dry white solid (3.90 g, 98%). 
 
Preparation of 2,4,6-Triisopropylbenzenesulfonohydrazine (186).[77] 
 
 
First attempt 
 
Two equivalents of hydrazine hydrate were added dropwise to a solution of sulfonyl 
chloride in tetrahydrofuran at -10  °C.  This was warmed to 0  °C and stirred for three 
hours.  The crude mixture was kept cold whilst the work up was carried out using ice-cold 
brine and removing the solvent in vacuo at 15  °C.  The white solid that was meant to form 
was yellow.  On analysis by 1H NMR, the yellow solid proved to be mostly starting 
material. 
 
Second attempt 
 
2,4,6-Triisopropylbenzenesulphonochloride 185 (10.7 g, 35.0 mmol) in tetrahydrofuran 
(40 mL) was cooled to -10 °C and hydrazine hydrate (5.0 mL, 180 mmol, 5.0 equiv) was 
added dropwise over 30 min.  The reaction was then warmed to 0  °C and stirred at this 
temperature for 3 h.  Water was added to dissolve any precipitated solids in the flask.  The 
mixture was transferred to a separating funnel and the aqueous layer was discarded.  The 
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organic layer was washed with ice cold brine and was then dried over sodium sulfate at 0 
°C for 1.5 h (placed in the fridge).  Sodium sulfate was filtered off and the solution was 
concentrated in vacuo (water bath at less than 15  °C – ice added to bath).  The white solid 
was washed several times with petroleum ether before being titurated with ice cold water 
and dried under vacuum for 2 h.  The product was obtained as a dry white solid (9.10 g, 
87%) which was stored in the freezer at -20 °C.    
 
1H NMR: 7.19 (s, 2H, Ar), 5.44 (br s, 1H, NH), 4.12 (sept, 2H, J = 6.9 Hz, CH (o)), 3.26 
(br s, 2H, NH2) 2.88 (sept, 1H, J = 6.9 Hz, CH (p)), 1.25 (d, 12H, J = 6.9 Hz, (CH3)2 (o)), 
1.24 (d, 6H, J = 6.9 Hz, (CH3)2 (p)).   
 
 
Preparation of Dimethyl (diazomethyl)phosphonate (DAMP).[82] 
 
 
 
A mixture of sodium azide (1.68 g, 25.8 mmol, 1.20 equiv), acetonitrile (30 mL) and mesyl 
chloride (1.83 mL, 1.10 equiv) was stirred overnight at room temperature.  The mixture 
was cooled in an ice bath and dimethyl 2-oxopropylphosphonate (2.50 g, 21.5 mmol) was 
added.  After 10 min, cesium carbonate (7.10 g, 1.00 equiv) was added and the mixture 
was stirred in the ice bath for 1 h.  The ice bath was then removed and the reaction mixture 
was stirred at room temperature for 2 h before being cooled to 0  °C.  Methanol (10 mL) 
was added within 5 min and the reaction was stirred for 4.5 h at 0  °C.  The ice bath was 
then removed and the mixture was diluted with toluene, stirred for a further 5 min and then 
filtered through celite.  The filter cake was washed with toluene several times.  The crude 
product was diluted further with toluene and concentrated in vacuo until the mixture had 
reduced by half.  The oily layer was separated from the top straw coloured layer by 
decanting it off carefully.  The oily layer was then washed with several portions of toluene 
and added to the decanted layer.  The solvent was then removed in vacuo and the product 
was then co evaporated with hexane and toluene to give a straw-coloured oil (2.94 g, 91%).           
 
1H NMR: (δH): 3.76 (d, 1H, J = 11.0 Hz), 3.77 (d, 6H, J = 11.7 Hz). 
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Methyl 3-[(1S)-1-Methyl-2-oxocyclohexyl]propanoate (183). 
 
 
 
2-Methylcyclohexanone (10 mL, 82.3 mmol), (R)-(+)-α-methylbenylamine (10 mL, 84.5 
mmol, 1.10 equiv) and p-TsOH (30.0 mg, 0.2 mol%) were dissolved in toluene (50 mL).  
The mixture was heated to reflux with a Dean-Stark apparatus attached.  After 3 h, once 
cool, the solvent was removed in vacuo, and methyl acrylate (8.0 mL, 85 mmol, 1.1 equiv) 
was added.  The resulting mixture was stirred at room temperature for ten days.  The 
reaction was quenched with 10% aqueous acetic acid (30 mL) and the aqueous and organic 
layers were separated.  The aqueous layer was extracted with diethyl ether and the 
combined organic extracts were washed with brine, dried over anhydrous magnesium 
sulphate, filtered and concentrated in vacuo.  The crude mixture was purified by flash 
column chromatography (ethyl acetate/petroleum ether: 1/9) which gave 183 as a pale 
yellow oil (9.98 g, 70%). 
 
[α]22 D: -9.25 (c 1.2, CH2Cl2).  
 
1H NMR (δH): 3.66 (s, 3H, OMe), 2.42-2.36 (m, 2H, H-8), 2.15 (ddd, 1H, J = 16.3, 11.2, 
5.3 Hz, H-2), 2.04 (ddd, 1H, J = 16.2, 11.1, 5.2 Hz, H-2), 1.75 (m, 8H, H-3, H-4, H-5 and 
H-7), 1.06 (s, 3H, Me-6).   
 
13C NMR (δC): 214.3 (C-1), 173.1 (C-9), 50.7 (OMe), 47.0 (C-6), 38.3, 37.8, 31.6, 28.0, 
26.5 (CH2), 21.4 (Me-6), 20.0 (CH2). 
 
MS: 199 (M+H)+, 168.  
 
IR (film): 2939, 2862, 1728, 1705, 1435, 1373, 1303, 1257, 1172, 1126 cm-1. 
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(2S)-2-(3-Hydroxypropyl)-2-methylcyclohexan-1-ol (145). 
 
 
A solution of keto ester 183 (8.63 g, 43.4 mmol) in tetrahydrofuran (60 mL) was added 
dropwise to a suspension of lithium aluminium hydride (4.12 g, 108 mmol, 2.50 equiv) in 
tetrahydrofuran (100 mL) at 0  °C.  The resulting mixture was allowed to warm to room 
temperature and stir overnight.  After cooling to 0  °C, saturated aqueous ammonium 
chloride was added dropwise until the fizzing stopped and the aluminium salts had crashed 
out giving a white solid.  The white salts were filtered off over a pad of celite and washed 
thoroughly with diethyl ether.  The aqueous and organic layers were separated and the 
aqueous layer was extracted with ether.  The combined organic layers were washed with 
brine, dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo to give 
145 as a 1:1 mixture of diastereomers as a colourless oil (6.41 g, 86%). 
 
1H NMR (δH): 3.62 (m, 2H, H-9), 3.44-3.33 (m, 1H, H-1), 1.97-1.76 (m, 2H, OH), 1.72-
1.22 (m, 11H, H-2, H-3, H-4, H-5, H-7, H-8), 1.08-0.98 (m, 1H, CH2) 0.98 (s, 1.7H, Me-
6), 0.86 (s, 1.3H, Me-6).  
 
13C NMR (δC): 76.7 (C-1), 75.2 (C-1), 63.0 (C-9), 63.0 (C-9), 36.2 (CH2), 35.8 (CH2), 34.2 
(CH2), 33.4 (CH2), 29.7 (CH2), 28.8 (CH2), 25.5 (CH2), 25.3 (CH2), 23.5 (CH2), 22.8 (Me-
6), 22.1 (CH2), 20.4 (CH2), 20.3 (CH2), 16.3 (Me-6).  
 
MS: 199 (M+H)+, 168. 
 
IR (film): 3271, 2931, 2862, 1450, 1373, 1342, 1118, 1057 cm-1. 
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(2S)-2-Methyl-2-[3-(triphenylmethoxy)propyl]cyclohexan-1-ol (184).  
 
 
To a solution of 145 (5.20 g, 30.1 mmol) in dichloromethane (90 mL) was added 4-
dimethylamino-N-triphenylmethyl pyridinium chloride (13.6 g, 33.9 mmol, 1.10 equiv).  
The resulting mixture was refluxed overnight.  Once cool, diethyl ether (300 mL) was 
added and the resulting white salts were filtered off.  The solution was dried over 
anhydrous magnesium sulfate, filtered and dried in vacuo.  The crude oil was purified by 
flash column chromatography (diethyl ether/petroleum ether: 3/7) to give a white sticky oil 
184 as a 1:1 mixture of diastereomers (11.5 g, 92%).   
 
1H NMR (δH): 7.51-7.47 (m, 6H, H-Ar), 7.33-7.27 (m, 6H, H-Ar), 7.29-7.22 (m, 3H, H-
Ar), 3.44-3.34 (m, 1H, H-1), 3.14-3.03 (m, 2H, H-9), 1.75-1.15 (m, 12H, CH2), 0.96 (s, 
1.5H, Me-6), 0.89 (s, 1.5H, Me-6) . 
 
13C NMR (δC): 144.5 (C-Ar), 127.8 (C-Ar), 126.8 (C-Ar), 126.0 (C-Ar), 85.5 (CPh3), 
63.1(C-1), 64.8 (C-9), 36.9 (C-6), 34.9 (CH2), 34.1 (CH2), 30.4 (CH2), 29.6 (CH2), 24.0 
(CH2), 21.2 (Me-6), 17.1 (CH2). 
 
MS: 243 (+CPh3). 
 
IR (film): 3063, 2931, 1705, 1489, 1450, 1219, 1157, 1080, 1033, 1003 cm-1. 
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(2S)-2-Methyl-2-[3-(triphenylmethoxy)propyl]cyclohexan-1-one (146).   
 
 
 
A solution of 2-iodoxybenzoic acid (9.33 g, 33.3 mmol, 1.20 equiv) in dimethyl sulfoxide 
(90 mL) was added to a solution of the crude mixture of diastereomers 184 (11.5 g, 27.7 
mmol) in tetrahydrofuran (90 mL).  The resulting mixture was stirred at room temperature 
overnight.  Water was added and the organic phase was diluted with diethyl ether.  The 
resulting white salts were filtered off and the aqueous layer was extracted with diethyl 
ether.  The combined organic layers were washed with brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo.  The crude mixture was purified via 
flash column chromatography (diethyl ether/petroleum ether: 1/9) to afford 146 as a white 
solid (10.0 g, 88% yield). 
 
M.p: 116-118  °C. 
 
1H NMR (δH): 7.44-7.40 (m, 6H, H-Ar), 7.31-7.27 (m, 6H, H-Ar), 7.24-7.20 (m, 3H, H-
Ar), 3.08-3.00 (m, 2H, H-9), 2.44-2.28 (m, 2H, H-2), 1.94-1.84 (m, 1H, CH2), 1.79-1.70 
(m, 4H, CH2), 1.69-1.54 (m, 3H, CH2), 1.46-1.31 (m, 2H, CH2), 1.04 (s, 3H, Me-6). 
 
13C NMR (δC): 215.1 (C-1), 143.5 (C-Ar), 127.8 (C-Ar), 126.8 (C-Ar), 126.0 (C-Ar), 85.5 
(CPh3), 63.1 (C-9), 47.5 (C-8), 38.4 (C-6), 37.8 (C-2), 33.1 (CH2), 26.6 (CH2), 23.6 (CH2), 
21.6 (Me-6), 20.2 (CH2). 
 
MS: 243 (+CPh3). 
 
IR (film): 3063, 2931, 1705, 1489, 1450, 1219, 1157, 1080, 1033, 1003, 748, 694 cm-1. 
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N'-[(1E,2S)-2-Methyl-2-[3-(triphenylmethoxy)propyl]cyclohexylidene]-
2,4,6-tris(propan-2-yl)benzene-1-sulfonohydrazide (156). 
 
 
 
First attempt 
 
The hydrazine was then reacted with ketone 146 and concentrated hydrochloric acid in 
order to form the hydrazone.  The experimental conditions used previously[71a] were 
applied to the reaction: one equivalent of the ketone and hydrazine were dissolved in five 
mL tetrahydrofuran.  Two drops of concentrated hydrochloric acid were then added to the 
reaction and it was left to stir at room temperature for one hour.  After work up and 
purification, the yield was 30%.   
 
Second attempt 
 
To a solution of ketone 146 (1.00 g, 2.42 mmol) in tetrahydrofuran (10 mL) was added 
triisopropylbenzenesulfonohydrazine 186 (0.90 g, 2.7 mmol, 1.1 equiv).  The solution was 
stirred until both solids had dissolved.  Concentrated hydrochloric acid (4 drops) were 
added to the solution, which was then stirred for 2 h at room temperature.  The reaction 
was quenched with saturated aqueous sodium hydrogencarbonate.  The two phases were 
separated and the aqueous layer was extracted with diethyl ether.  The combined organic 
layers were washed with brine, dried over anhydrous magnesium sulfate, filtered and the 
solvent was removed in vacuo.  The crude product was purified by flash column 
chromatography (diethyl ether/petroleum ether: 20/80) and gave 156 as a white solid (1.45 
g, 87%).  
 
M.p: 74-77  °C. 
 
1H NMR (δH): 7.40-7.36 (m, 7H, N-H, H-Ar), 7.30-7.26 (m, 9H, H-Ar), 7.10 (s, 2H, H-
Ar’), 4.19 (septet, 2H, J = 6.7 Hz, ArCH(CH3)2), 2.91 (dt, 2H, J = 6.2, 1.2 Hz, H-9), 2.81 
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(septet, 1H, J = 6.9 Hz, ArCH(CH3)2), 2.34 (dt, 1H, J = 14.6, 4.6 Hz, H-2), 1.97-1.89 (m, 
1H, H-2), 1.76-1.69 (m, 2H, CH2), 1.65-1.53 (m, 4H, CH2),  1.48-1.36 (m, 3H, CH2), 1.22 
(2d, 12H, J = 6.7 Hz, ArCH(CH3)2), 1.18 (2d, 6H, J = 6.9 Hz, ArCH(CH3)2), 1.08-1.02 (m, 
1H, CH2), 0.88 (s, 3H, Me-6).  
 
13C NMR (δC): 162.5 (C-1), 152.1 (C-Ar’), 150.3 (C-Ar’), 143.6 (C-Ar), 130.7 (C-Ar’), 
127.9 (C-Ar), 126.8 (C-Ar), 126.0 (C-Ar), 122.5 (C-Ar’), 85.6 (CPh3), 63.1 (C-9), 41.0 (C-
6), 38.4 (CH2), 33.7, 33.2 (ArCH(CH3)2), 29.9, 29.0, 24.9, 23.9, 23.9, 23.4 (ArCH(CH3)2), 
23.3 (CH2), 22.6 (CH2), 22.0 (CH2), 20.0 (CH3). 
 
MS: 691 (M-H)-. 
 
IR (film): 2924, 2862, 2623, 2407, 2291, 2252, 2191, 2075, 1982, 1597, 1458, 1319, 1157, 
1072, 1018 cm-1. 
 
3,3-Dimethyl-oct-1-en-6-yn-4-ol ((±)-188). 
 
 
 
First attempt 
 
A solution of 3-pentynol (0.9 mL, 9.75 mmol) in dichloromethane (5 mL) was added to a 
stirred solution of Dess-Martin periodinane (4.55 g, 10.7 mmol, 1.10 equiv) in 
dichloromethane (25 mL).  Water (1 drop) was added to the mixture.  After stirring for 1 h 
at room temperature, the reaction was cooled to -78  °C and pentane was added (10 mL).  
This was then filtered through a pad of silica gel and the crude product was concentrated in 
vacuo at room temperature.  No crude product was obtained as it had been lost through the 
vacuum.  The reaction was repeated, but this time the product was concentrated in vacuo 
between 5 and 10  °C.  The crude product was still lost through the vacuum. 
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Second attempt 
 
A solution of 3-pentynol (5.0 mL, 59 mmol) in dichloromethane (20 mL) was added to a 
stirred solution of Dess-Martin periodinane (30.0 g, 71.3 mmol, 1.20 equiv) in 
dichloromethane (120 mL). Water (2 drops) was added to the mixture.  After stirring for 1 
h at room temperature, the reaction was cooled to -78 °C and filtered through a pad of 
silica gel.  The crude product was left dissolved in dichloromethane.  Tetrahydrofuran (75 
mL) was added to the crude mixture before an excess of freshly prepared 1-bromo-3-
methylbut-2-ene (15 mL, 71.3 mmol, 1.20 equiv) was added.  Saturated aqueous 
ammonium chloride (75 mL) was added to the mixture before being cooled to 0 °C and 
zinc dust (11.6 g, 178.2 mmol, 3.00 equiv) was added slowly.  The mixture was warmed to 
room temperature and stirred vigorously for 1 h (no inert atmosphere is necessary).  After 1 
h the reaction mixture was filtered through a pad of celite and the two phases were 
separated.  The aqueous layer was extracted with diethyl ether before the combined organic 
fractions were washed with brine, dried over anhydrous magnesium sulfate and filtered.  
The solvent was removed in vacuo and the product was purified by flash column 
chromatography (diethyl ether/petroleum ether: 5/95) which gave a pale yellow oil (8.23 g, 
91% over two steps).   
 
1H NMR (δH): 5.85 (dd, 1H, J = 17.5 10.8 Hz, H-7), 5.08-5.01 (m, 2H, H-8), 3.45 (dt, 1H, 
J = 10.0, 3.1 Hz, H-5), 2.36 (dq, 1H, J = 16.5, 2.6 Hz, H-4), 2.20-2.09 (m, 2H, H-4, OH), 
1.80 (t, 3H, J = 2.5 Hz, H-1), 1.03 (s, 3H Me-6), 1.02 (s, 3H, Me-6). 
 
13C NMR (δC): 144.6 (C-7), 113.2 (C-8), 78.3 (C-3), 76.7 (C-5), 76.5 (C-2), 41.1 (C-6), 
23.1 (C-4), 23.0 (Me-6), 22.7 (Me-6), 3.7 (C-1). 
 
MS: 154.3 (M+H)+, 135.3. 
 
IR (film): 3506, 3082, 2966, 2920, 2874, 1793, 1728, 1693, 1465, 1450, 1415, 1377, 1365, 
1273, 1068, 1041 cm-1. 
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3,3-Dimethyloct-1-en-6-yn-4-one (176). 
 
 
 
A solution of (±)-188 (8.22 g, 54.0 mmol) in dichloromethane (20 mL) was added to a 
solution of Dess-Martin periodinane (27.5 g, 64.8 mmol, 1.20 equiv) in dichloromethane 
(150 mL).  Water (2 drops) was also added to the mixture.  After stirring at room 
temperature for 2 h, the reaction mixture was cooled to -78 °C.  The cold mixture was 
filtered through a pad of silica gel and the crude product was concentrated in vacuo.  The 
product was purified by flash column chromatography (diethyl ether/petroleum ether: 3/97) 
which gave a pale yellow oil (8.00 g, 99%). 
 
1H NMR (δH): 5.91 (dd, 1H, J = 17.2 10.3 Hz, H-7), 5.19-5.15 (m, 2H, H-8), 3.36 (q, 2H, J 
= 2.5 Hz, H-4), 1.83 (t, 3H, J = 2.5 Hz, H-1), 1.25 (s, 3H, Me-6), 1.25 (s, 3H, Me-6). 
 
13C NMR (δC): 207.1 (C-5), 142.0 (C-7), 115.1 (C-8), 80.1 (C-3), 71.6 (C-2), 50.9 (C-6), 
29.4 (C-4), 23.7 (Me-6), 3.8 (C-1). 
 
MS: 151.3 (M+H)+, 121.2. 
 
IR (film): 2974, 2924, 1720, 1635, 1465, 1442, 1365, 1319, 1234, 1207, 1126, 1060, 1018 
cm-1.  
 
 
2-(2-Methylbut-3-en-2-yl)-2-[(trimethylsilyl)oxy]hex-4-ynenitrile ((±)-
189). 
 
 
 
To a stirred solution of ketone 176 (8.14 g, 54.1 mmol) and zinc iodide (2.59 g, 8.12 mmol, 
0.15 equiv) in dichloromethane (80 mL) was added trimethylsilyl cyanide (8.2 mL, 65 
 132 
mmol).  The mixture was stirred at room temperature overnight.  Excess solvent and 
trimethylsilyl cyanide were removed in vacuo using a bleach and sodium hydroxide (1 M) 
trap.  The crude residue was purified by flash column chromatography (diethyl 
ether/petroleum ether: 2/98) and gave a pale yellow oil (12.2 g, 99%). 
 
1H NMR (δH): 5.95 (dd, 1H, J = 17.4 Hz, 10.9 Hz, H-7), 5.14-5.09 (m, 2H, H-8), 2.63 (dq, 
1H, J = 16.8 Hz, 2.5 Hz, H-4), 2.44 (dq, 1H, J = 16.8 Hz, 2.5 Hz, H-4), 1.81 (t, 3H, J = 2.6 
Hz, H-1), 1.18 (s, 3H, Me-6), 1.13 (s, 3H, Me-6), 0.29 (s, 9H, H-TMS). 
 
13C NMR (δC): 141.7 (C-7) 119.8 (C-N), 115.2 (C-8), 80.5 (C-3) 79.2 (C-2), 74.4 (C-5), 
45.4 (C-6), 28.7 (C-4), 22.8 (Me-6), 22.1 (Me-6), 3.8 (C-1), 1.64 (C-TMS). 
 
MS: 150.2 (M+H)+. 
 
IR (film): 3087, 2969, 2926, 2249, 1640, 1465, 1379, 1255, 1139, 1004 cm-1. 
 
 
2-(2-Methylbut-3-en-2-yl)-2-[(trimethylsilyl)oxy]hex-4-ynal ((±)-177). 
 
 
 
First attempt 
 
Nitrile (±)-189 (220 mg, 0.88 mmol) was dissolved in dichloromethane (10 mL) and 
cooled to -78 °C.  DIBAL (2.21 mL, 1 M in hexanes, 2.21 mmol, 2.50 equiv, Aldrich) was 
then added dropwise.  The reaction mixture was warmed to 0 °C and stirred for 2 h.  The 
reaction was quenched with ethyl acetate, diluted with diethyl ether and allowed to warm 
to room temperature.  Silica was added to the solution, which was then placed at -20 °C 
overnight.  After completion of the reaction, the mixture was warmed to room temperature 
and the silica was filtered off.  Solvents were evaporated under reduced pressure.  The 
crude 1H NMR of the product showed many signals and after attempting purification the 
desired product was not obtained. 
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Second attempt 
 
Nitrile (±)-189 (230 mg, 0.90 mmol) was dissolved in dichloromethane (10 mL) and 
cooled to -78 °C.  DIBAL (2.23 mL, 1 M in hexanes, 2.23 mmol, 2.50 equiv, Aldrich) was 
then added dropwise.  The reaction mixture was warmed to 0 °C and stirred for 2 h.  The 
reaction was quenched with ethyl acetate, diluted with diethyl ether and allowed to warm 
to room temperature.  The reaction was quenched with 1 M aq HCl (5 mL) and stirred for 1 
h.  Solvents were evaporated under reduced pressure.  The crude 1H NMR spectrum of the 
product again showed many signals and purification was not carried out.  
 
Third attempt 
 
Nitrile (±)-189 (3.00 g, 12.0 mmol) was dissolved in hexane (275 mL) and cooled to -78 
°C.  Fresh diisobutylaluminium hydride (17.0 mL, 1 M in hexanes, 1.40 equiv, Fisher) was 
added dropwise and the reaction mixture was allowed to warm to 0 °C.  The mixture was 
stirred at 0 °C for 2 h.  The reaction was quenched with ethyl acetate and diluted with 
diethyl ether.  Saturated aqueous ammonium chloride was added to the mixture and stirred 
at 0 °C for 45 min until a precipitate started to form.  The mixture was filtered through 
celite and dried over anhydrous sodium sulfate.  The solvent was removed in vacuo and the 
crude product was purified by flash column chromatography (diethyl ether/petroleum 
ether: 1/99) which gave a colourless oil 177 (1.87 g, 69%). 
 
1H NMR (δH): 9.63 (s, 1H, CHO), 5.96 (dd, 1H, J = 17.5 10.8, Hz, H-7), 5.09-4.98 (m, 2H, 
H-8), 2.75 (dq, 1H, J = 16.8, 2.6 Hz, H-4), 2.37 (dq, 1H, J = 16.8, 2.6 Hz, H-4), 1.72 (t, 
3H, J = 2.6 Hz, H-1), 1.03 (s, 6H, Me-6), 0.21 (s, 9H, H-TMS). 
 
13C NMR (δC): 202.6 (CHO), 141.6 (C-7), 112.3 (C-8), 84.8 (C-3), 77.8 (C-2), 73.8 (C-5), 
43.1 (C-6), 22.1 (C-4), 22.5 (Me-6), 20.5 (Me-6) 2.2 (C-1), 1.3 (C-TMS). 
 
MS: 253.4 (M+H)+, 223.3, 171.3. 
 
IR (film): 3070, 2957, 2852, 2102, 1647, 1460, 1332, 1242, 1155, 1016 cm-1. 
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(2R)-2-Hydroxy-2-(2-methylbut-3-en-2-yl)hex-4- 
ynenitrile (227). 
 
  
 
To a stirred solution of ketone 176 (0.60 g, 4.10 mmol) in chloroform (0.2 M) at -20 °C 
was added (DHD)2AQN (1.10 g, 1.30 mmol, 30 mol%) and ethyl cyanoformate (0.80 mL, 
8.2 mmol, 2.0 equiv).  The resulting mixture was allowed to stand at that temperature in a 
freezer for 7 days without stirring.  Aqueous hydrochloric acid (1 M, 10 mL) was added to 
the reaction mixture.  The mixture was extracted with ether and the organic phase was 
washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated in 
vacuo.  The product was purified by flash column chromatography (diethyl 
ether/petroleum ether: 3/97) which gave the enantioenriched alcohol 227 as a yellow oil 
(0.40 g, 54%).  Potassium carbonate was added to the aqueous layer to adjust the pH of the 
solution to between 9-11.  The resulting solution was extracted with ethyl acetate (100 
mL), and the organic layer was washed with brine, dried over anhydrous sodium sulphate, 
filtered and concentrated in vacuo to give the recovered (DHD)2AQN) (0.88 g, 80%).  
 
[α]22 D: +29.1 (c 1.2, CH2Cl2).   
 
1H NMR (δH): 5.96 (dd, 1H, J = 17.5 Hz, 10.9 Hz, H-7), 5.22-5.11 (m, 2H, H-8), 3.12 (s, 
1H, OH), 2.64 (dq, 1H, J = 16.6 Hz, 2.5 Hz, H-4), 2.53 (dq, 1H, J = 16.7 Hz, 2.5 Hz, H-4), 
1.85 (t, 3H, J = 2.5 Hz, H-1), 1.22 (s, 3H, Me-6), 1.20 (s, 3H, Me-6). 
 
13C NMR (δC): 139.9 (C-7), 119.2 (C-N), 114.8 (C-8), 81.5 (C-3), 75.5 (C-2), 70.9 (C-5), 
42.3 (C-6), 27.1 (C-4), 21.4 (Me-6), 20.9 (Me-6), 2.7 (C-1). 
 
HRMS Calcd for C11H15NO: 177.1154. Found: 177.1151.  
 
IR (film): 3493, 2976, 2355, 1761, 1640, 1465, 1419, 1386, 1094, 1065 cm-1. 
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(1R,2R)-1-[(6S)-6-Methyl-6-[3-(triphenylmethoxy)propyl]cyclohex-1-en-
1-yl]-2-(2-methylbut-3-en-2-yl)hex-4-yne-1,2-diol 178a and (1S,2S)-1-
[(6S)-6-Methyl-6-[3-(triphenylmethoxy)propyl]cyclohex-1-en-1-yl]-2-(2-
methylbut-3-en-2-yl)hex-4-yne-1,2-diol 178b. 
 
 
 
First attempt 
 
To a stirred solution of hydrazone 156 (1.00 g, 1.44 mmol) in tetrahydrofuran (10 mL) at -
78 °C was added tert-butyllithium (3.60 mL, 1.6 M in pentane, 3.87 mmol, 3.00 equiv 
dropwise.  The solution turned red and was stirred at -78 °C for 30 min until the colour 
turned dark red.  The temperature was then allowed to warm to 0 °C to allow nitrogen 
evolution.  After 5 min, once bubbling has stopped, the solution was again cooled to -78 
°C.  A pre-cooled solution of aldehyde ((±)-177) (355 mg, 1.29 mmol, 0.9 equiv) in 
tetrahydrofuran (5 mL) was added dropwise and the resulting mixture was stirred at -78 °C 
for 5 h.  The reaction was quenched with saturated aqueous sodium hydrogencarbonate (10 
mL).  The phases were separated and the aqueous phase was extracted with diethyl ether.  
The combined organic extracts were washed with brine, dried over anhydrous magnesium 
sulfate, filtered and the solvent was removed in vacuo.  Starting material was recovered. 
 
Second attempt 
 
To a stirred solution of hydrazone 156 (1.00 g, 1.44 mmol) in tetrahydrofuran (10 mL) at -
78 °C was added tert-butyllithium (1.88 mL, 1.6 M in pentane, 3.05 mmol, 2.10 equiv) 
dropwise.  The solution turned red and was stirred at -78 °C for 30 min until the colour 
turned dark red.  The temperature was then allowed to warm to 0 °C to allow nitrogen 
evolution.  After 5 min, once bubbling has stopped, the solution was again cooled to -78 
°C.  A solution of cerium (III) chloride
 
(419 mg, 1.70 mmol, 1.2 equiv) in tetrahydrofuran 
(5 mL) was stirred for 4 h at room temperature, after which time it was cooled to -78 °C 
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and titrated with tert-butyllithium until the solution turned yellow.  This was then added 
dropwise to the previous solution at -78 °C and stirred for a further 30 min.  A pre-cooled 
solution of aldehyde ((±)-177) (355 mg, 1.29 mmol, 0.9 equiv) in tetrahydrofuran (5 mL) 
was added dropwise and the resulting mixture was stirred at -78 °C for 1 h.  The reaction 
was quenched with saturated aqueous sodium hydrogencarbonate (10 mL).  The phases 
were separated and the aqueous phase was extracted with diethyl ether.  The combined 
organic extracts were washed with brine, dried over anhydrous magnesium sulfate, filtered 
and the solvent was removed in vacuo.  Purification of the crude product using flash 
column chromatography (diethyl ether/petroleum ether:1/99) gave compound 201 as a 
yellow oil and as a 1:1 inseparable mixture of diastereomers (120 mg, 13%).   
 
Third attempt 
 
To a stirred solution of hydrazone 156 (1.00 g, 1.44 mmol) in tetrahydrofuran (10 mL) at -
78 °C was added tert-butyllithium (1.93 mL, 1.6 M in pentane, 3.10 mmol, 2.15 equiv 
dropwise.  The solution turned red and was stirred at -78 °C for 30 min until the colour 
turned dark red.  The temperature was then allowed to warm to 0 °C to allow nitrogen 
evolution.  After 5 min, once bubbling has stopped, the solution was again cooled to -78 
°C.  Two equivalents of lithium chloride (123.6 mg, 2.88 mmol) were added to cerium 
trichloride (355 mg, 1.44 mmol).  This was heated and stirred under vacuum overnight 
before being dissolved
 
in tetrahydrofuran (5 mL), this was stirred for 4 h at room 
temperature, after which time it was cooled to -78 °C and titrated with tert-butyllithium.  
The solution turned black and not yellow.  The aldehyde was not added and the reaction 
was abandoned. 
 
Fourth attempt 
 
To a stirred solution of hydrazone 156 (1.00 g, 1.44 mmol) in tetrahydrofuran (10 mL) at -
78 °C was added tert-butyllithium (1.93 mL, 1.6 M in pentane, 3.10 mmol, 2.15 equiv 
dropwise.  The solution turned red and was stirred at -78 °C for 30 min until the colour 
turned dark red.  The temperature was then allowed to warm to 0 °C to allow nitrogen 
evolution.  After 5 min, once bubbling has stopped, the solution was again cooled to -78 
°C.  A solution of cerium (III) chloride
 
(355 mg, 1.44 mmol) in tetrahydrofuran (5 mL) 
was stirred for 4 h at room temperature, after which time it was cooled to -78 °C and 
titrated with tert-butyllithium until the solution turned yellow.  This was then added 
dropwise to the previous solution at -78 °C and stirred for a further 30 min.  A pre-cooled 
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solution of aldehyde ((±)-177) (355 mg, 1.29 mmol, 0.9 equiv) in tetrahydrofuran (5 mL) 
was added dropwise and the resulting mixture was stirred at -78 °C for 1 h.  The reaction 
was quenched with saturated aqueous sodium hydrogencarbonate (10 mL).  The phases 
were separated and the aqueous phase was extracted with diethyl ether.  The combined 
organic extracts were washed with brine, dried over anhydrous magnesium sulfate, filtered 
and the solvent was removed in vacuo.  Purification of the crude product using flash 
column chromatography (diethyl ether/petroleum ether:1/99) gave a yellow oil as an 
inseparable mixture of 1:1 diastereomers (415 mg, 45%).  The crude mixture of two 
inseparable diastereomers was dissolved in tetrahydrofuran (10 mL) and cooled to 0 °C 
and 1 M aqueous hydrochloric acid (0.60 mL, 0.60 mmol, 2.0 equiv) was added.  The 
mixture was allowed to warm to room temperature and stirred overnight.  The reaction was 
quenched with saturated aqueous sodium hydrogencarbonate, the phases were separated 
and the aqueous phase was extracted with diethyl ether.  The combined organic extracts 
were washed with brine, dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo. The crude product was purified by flash column chromatography 
(diethyl ether/petroleum ether: 10/90) which allowed separation of the two diastereomers, 
undesired alcohol 178a as a colourless oil (98.0 mg, 50%) and desired alcohol 178b as a 
colourless oil (78.0 mg, 41%). 
 
(1R,2R)-1-[(6S)-6-Methyl-6-[3-(triphenylmethoxy)propyl]cyclohex-1-en-1-yl]-2-(2-
methylbut-3-en-2-yl)hex-4-yne-1,2-diol 178a. 
 
 
 
1H NMR (δH): 7.47-7.42 (m, 6H, H-Ar), 7.31-7.26 (m, 6H, H-Ar), 7.24 – 7.20 (m, 3H, H-
Ar), 6.27–6.18 (m, 2H, H-4, H-11), 5.07-5.01 (m, 2H, H-2’), 4.22 (d, 1H, J = 5.9 Hz, H-2), 
3.14 (s, 1H, OH (C-1)), 3.08-3.04 (m, 2H, H-1’), 2.52-2.48 (m, 2H, H-14), 2.16 (d, 1H, J = 
6.4 Hz, OH (C-2)), 2.07-1.98 (m, 2H, H-5), 1.78 (t, 3H, J = 2.6 Hz, H-18), 1.70-1.51 (m, 
6H, CH2), 1.49-1.41 (m, 2H, CH2), 1.20 (s, 3H, H-16 or H-17), 1.17 (s, 3H, H-17 or H-16), 
0.98 (s, 3H, H-19). 
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13C NMR (δC): 145.8 (C-3), 145.3 (C-Ar), 143.7 (C-11), 127.9 (C-Ar), 127.4 (C-4), 126.7 
(C-Ar), 125.8 (C-Ar), 111.4 (C-2’), 85.6 (CPh3), 78.4, 76.4, 75.6 (C-13, C-12, C-1), 68.2 
(C-2), 64.8 (C-1’), 45.5 (C-15), 36.2 (C-8), 35.9 (C-5), 34.5 (CH2), 25.3 (CH2), 25.2 (CH2), 
24.9 (C-14), 23.8 (C-19), 22.9 (C-16 or C-17), 22.4 (C-16 or C-17), 17.8 (CH2), 2.7 (C-
18).  
 
MS: 577 (M+H)+, 559. 
 
IR (film): 3517, 2920, 2867, 1490, 1448, 1152, 1115, 1088, 1070 cm-1. 
 
(1S,2S)-1-[(6S)-6-Methyl-6-[3-(triphenylmethoxy)propyl]cyclohex-1-en-1-yl]-2-(2-
methylbut-3-en-2-yl)hex-4-yne-1,2-diol 178b. 
 
 
 
1H NMR (δH): 7.45-7.43 (m, 6H, H-Ar), 7.32-7.27 (m, 6H, H-Ar), 7.25-7.20 (m, 3H, H-
Ar), 6.26-6.16 (m, 2H, H-4, H-11), 5.05-4.93 (m, 2H, H-2’), 4.24 (d, 1H, J = 6.4 Hz, H-2), 
3.09 (s, 1H, OH (C-1)), 3.04 (t, 2H, J = 6.1 Hz, H-1’), 2.52-2.43 (m, 2H, H-14), 2.05-1.99 
(m, 3H, H-5, OH (C-2)), 1.66 (t, 3H, J = 2.8 Hz, H-18), 1.62-1.48 (m, 5H, CH2), 1.45-1.37 
(m, 3H, CH2), 1.18 (s, 3H, H-16 or H-17), 1.15 (s, 3H, H-17 or H-16), 1.07 (s, 3H, H-19). 
 
13C NMR (δC): 146.6 (C-3), 145.8 (C-Ar), 143.7 (C-11), 127.8 (C-Ar), 126.8 (C-Ar), 126.6 
(C-4), 125.9 (C-Ar), 111.4 (C-2’), 85.6 (Ph3C), 78.5, 76.5, 75.6 (C-13, C-12, C-1), 68.9 (C-
2), 64.8 (C-1’), 45.6 (C-15), 35.9 (C-8), 35.0 (C-5), 34.2 (CH2), 25.4 (CH2), 25.0 (C-19), 
24.2 (CH2), 23.6 (C-14), 22.9 (C-16 or C-17), 22.5 (C-16 or C-17), 17.7 (CH2), 2.6 (C-18).   
 
MS: 577 (M+H)+, 559. 
IR (film): 3517, 2922, 1448, 1379, 1002 cm-1. 
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(1R,2R)-1-[(6S)-6-(3-Hydroxypropyl)-6-methylcyclohex-1-en-1-yl]-2-(2-
methylbut-3-en-2-yl)hex-4-yne-1,2-diol 204a and (1S,2S)-1-[(6S)-6-(3-
Hydroxypropyl)-6-methylcyclohex-1-en-1-yl]-2-(2-methylbut-3-en-2-
yl)hex-4-yne-1,2-diol 204b. 
 
 
 
To a solution of 178a (103 mg, 0.30 mmol) in methanol (5 mL) was added Amberlyst (500 
mg).  The mixture was stirred at room temperature overnight.  The Amberlyst was filtered 
off and washed thoroughly with ethyl acetate before the solvent was removed in vacuo.  
Purification of the product by column chromatography (ethyl acetate/petroleum ether: 
25/75) gave 204a as a colourless oil (41.0 mg, 68%). 
 
The same procedure was used with 178b (95.0 mg, 0.16 mmol) and gave the desired 
carbonate 204b as a colourless oil (46.0 mg, 85%). 
 
(1R,2R)-1-[(6S)-6-(3-Hydroxypropyl)-6-methylcyclohex-1-en-1-yl]-2-(2-methylbut-3-
en-2-yl)hex-4-yne-1,2-diol 204a. 
 
 
 
1H NMR (δH): 6.30-6.23 (m, 2H, H-4, H-11), 5.09-5.06 (m, 2H, H-2’), 4.28 (d, 1H, J = 4.2 
Hz, H-2), 3.61 (t, 2H, J = 6.6 Hz, H-1’), 3.05 (s, 1H, OH (C-1)), 2.53-2.50 (m, 2H, H-14), 
2.06-2.00 (m, 3H, H-5, OH (C-2)), 1.79 (t, 3H, J = 2.7 Hz, H-18), 1.66-1.59 (m, 2H, CH2), 
1.57-1.50 (m, 4H, CH2), 1.40-1.32 (m, 2H, CH2), 1.24 (s, 3H, H-16 or H-17), 1.20 (s, 3H, 
H-17 or H-16), 1.09 (s, 3H, H-19).   
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13C NMR (δC): 146.3 (C-3), 144.9 (C-11), 128.9 (C-4), 112.6 (C-2’), 79.6, 77.1, 76.2 (C-
13, C-12, C-1), 68.7 (C-2), 62.9 (C-1’), 46.4 (C-15), 37.4 (C-8), 35.9 (C-5), 35.2 (CH2), 
27.1 (CH2), 26.9 (CH2), 26.1 (C-19), 25.9 (C-14), 23.8 (C-16 or C-17), 23.2 (C-17 or C-
16), 18.8 (CH2), 3.7 (C-18). 
 
MS: 335 (M+H)+. 
 
IR (film): 3636, 3456, 3082, 2924, 2868, 2735, 2669, 1723, 1633, 1460, 1416, 1383, 1236, 
1063, 1004 cm-1. 
 
(1S,2S)-1-[(6S)-6-(3-Hydroxypropyl)-6-methylcyclohex-1-en-1-yl]-2-(2-methylbut-3-
en-2-yl)hex-4-yne-1,2-diol 204b. 
 
 
 
1H NMR (δH): 6.29 (t, 1H, J = 4.1 Hz, H-4), 6.21 (dd, 1H, J = 17.8, 10.5 Hz, H-11), 5.08-
5.04 (m, 2H, H-2’), 4.23 (s, 1H, H-2), 3.72-3.67 (m, 1H, H-1’), 3.64-3.50 (m, 2H, OH, H-
1’), 3.05 (s, 1H, OH), 2.52-2.45 (m, 2H, H-14), 2.03-1.97 (m, 2H, H-5), 1.75 (t, 3H, J = 2.6 
Hz, H-18), 1.73-1.65 (m, 1H, CH2), 1.60-1.51 (m, 4H, CH2), 1.44-1.33 (m, 3H, CH2), 1.19 
(s, 3H, H-16 or H-17), 1.17 (s, 3H, H-17 or H-16), 0.99 (s, 3H, H-19). 
 
13C NMR (δC): 147.1 (C-3), 146.8 (C-11), 127.7 (C-4), 112.6 (C-2’), 79.3, 77.5, 76.6 (C-
13, C-12, C-1), 69.8 (C-2), 63.8 (C-1’), 46.4 (C-15), 36.6 (C-8), 35.3 (C-5), 35.0 (CH2), 
27.1 (CH2), 26.2 (CH2), 25.8 (C-19), 25.1 (C-14), 23.7 (C-16 or C-17), 23.3 (C-17 or C-
16), 18.5 (CH2), 3.7 (C-18). 
 
MS: 335 (M+H)+. 
 
IR (film): 3636, 3533, 2932, 2867, 1460, 1380, 1117, 1048, 1008 cm-1. 
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(4R,5R)-4-(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-[3-
(triphenylmethoxy)propyl]cyclohex-1-en-1-yl]-4-(2-methylbut-3-en-2-yl)-
1,3-dioxolan-2-one 213a and (4S,5S)-4-(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-
[3-(triphenylmethoxy)propyl]cyclohex-1-en-1-yl]-4-(2-methylbut-3-en-2-
yl)-1,3-dioxolan-2-one 213b. 
 
 
 
To a solution of 178a (300 mg, 0.52 mmol) in dimethylformamide (10 mL) was added 
sodium hydride (70 mg, 60% in mineral oil, 1.7 mmol, 2.5 equiv) and carbonyl 
diimidazole (0.50 g, 2.6 mmol, 5.0 equiv).  The mixture was stirred at room temperature 
for 30 min before being quenched with saturated aqueous ammonium chloride.  The 
aqueous layer was extracted with diethyl ether and the combined organic layers were 
washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated in 
vacuo.  Purification of the product by flash column chromatography (diethyl 
ether/petroleum ether: 20/80) gave 213a as a thick white oil (185 mg, 61%). 
 
The same procedure was used with 178b (300 mg, 0.52 mmol) and gave the desired 
carbonate 213b as a white solid (190 mg, 61%). 
 
(4R,5R)-4-(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-[3-(triphenylmethoxy)propyl]cyclohex-
1-en-1-yl]-4-(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 213a. 
 
 
[α]24 D: +21.5 (c 0.2, CH2Cl2). 
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1H NMR (δH): 7.46-7.42 (m, 6H, H-Ar), 7.32-7.27 (m, 6H, H-Ar), 7.25–7.20 (m, 3H, H-
Ar), 6.04–5.94 (m, 2H, H-4, H-11), 5.19-5.13 (m, 2H, H-2’), 4.94 (s, 1H, H-2), 3.07-3.02 
(m, 2H, H-1’), 2.81-2.65 (m, 2H, H-14), 2.15-2.07 (m, 2H, H-5), 1.75 (t, 3H, J = 2.5 Hz, 
H-18), 1.67-1.52 (m, 5H, CH2), 1.41-1.30 (3H, m, CH2), 1.21 (s, 3H, H-16 or H-17), 1.19 
(s, 3H, H-16 or H-17), 0.99 (s, 3H, H-19).  
 
13C NMR (δC): 154.0 (C=O), 143.4 (C-3), 140.9 (C-11), 137.4 (C-Ar), 132.5 (C-4), 127.8 
(C-Ar), 126.8 (C-Ar), 125.9 (C-Ar), 115.0 (C-2’), 85.5 (CPh3), 78.2, 76.7, 76.3 (C-13, C-
12, C-1), 73.1 (C-2), 63.2 (C-1’), 45.3 (C-15), 36.0 (CH2), 35.8 (CH2), 34.2 (C-8), 25.9 (C-
19), 24.9 (C-5), 23.3 (CH2), 22.5 (C-14), 21.9 (C16 or 17), 20.4 (C16 or C-17), 17.5 (CH2), 
2.8 (C-18).  
 
HRMS Calcd for C41H46O4Na: 625.3288. Found: 625.3262. 
 
IR (film): 3057, 2935, 2866, 1799, 1448, 1195, 1174, 1060, 1041, 1003 cm-1. 
 
(4S,5S)-4-(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-[3-triphenylmethoxy)propyl]cyclohex-1-
en-1-yl]-4-(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 213b. 
 
 
 
[α]24 D: +4.5 (c 0.2, CH2Cl2). 
 
1H NMR (δH): 7.47-7.42 (m, 6H, H-Ar), 7.34-7.28 (m, 6H, H-Ar), 7.27–7.21 (m, 3H, H-
Ar), 5.99–5.88 (m, 2H, H-4, H-11), 5.17-5.03 (m, 2H, H-2’), 5.01 (s, 1H, H-2), 3.04 (t, 2H, 
J = 6.3 Hz, H-1’), 2.84-2.62 (m, 2H, H-14), 2.15-2.09 (m, 2H, H-5), 1.65 (t, 3H, J = 2.5 
Hz, H-18), 1.63-1.53 (m, 5H, CH2), 1.47-1.30 (3H, m, CH2), 1.18 (s, 3H H-16 or H-17), 
1.18 (s, 3H H-16 or H-17), 1.09 (s, 3H, H-19).  
 
13C NMR (δC): 153.8 (C=O), 143.3 (C-3), 140.9 (C-11), 139.2 (C-Ar), 130.8 (C-4), 127.6 
(C-Ar), 126.8 (C-Ar), 126.0 (C-Ar), 114.9 (C-2’), 85.5 (CPh3), 78.2 (C-13), 77.4 (C-1), 
 143 
76.3 (C-12), 73.0 (C-2), 63.2 (C-1’), 45.2 (C-15), 35.5 (CH2), 34.9 (CH2), 33.7 (C-8), 24.8 
(C-19), 23.8 (C-5), 23.3 (CH2), 22.5 (C-14), 21.9 (C16 or 17), 20.3 (C16 or C-17), 17.2 
(CH2), 2.7 (C-18).  
 
HRMS Calcd for C41H46O4Na: 625.3288. Found: 625.3267. 
 
IR (film): 3517, 2922, 1448, 1379, 1002 cm-1. 
 
 
(4R,5R)-4-(but-2-yn-1-yl)-5-[(6S)-6-(3-hydroxypropyl)-6-methylcyclohex-
1-en-1-yl]-4-(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 214a and (4S,5S)-
4-(but-2-yn-1-yl)-5-[(6S)-6-(3-hydroxypropyl)-6-methylcyclohex-1-en-1-
yl]-4-(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 214b. 
 
 
 
To a solution of 213a (185 mg, 0.30 mmol) in wet methanol (7 mL) was added Amberlyst 
H-15 (300 mg).  The mixture was stirred overnight at room temperature.  The resin was 
filtered off and washed thoroughly with ethyl acetate.  The solvent was then removed in 
vacuo.  The crude mixture was purified by flash column chromatography (diethyl 
ether/petroleum ether: 20/80) and gave 214a as a colourless oil (55.0 mg, 50%). 
 
The same procedure was used with 213b (190 mg, 0.31 mmol) and gave the desired 
alcohol 214b as a colourless oil (102 mg, 90%). 
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(4R,5R)-4-(But-2-yn-1-yl)-5-[(6S)-6-(3-hydroxypropyl)-6-methylcyclohex-1-en-1-yl]-4-
(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 214a. 
 
 
 
 
[α]21.9 D: +2.6 (c 0.1, CH2Cl2). 
 
1H NMR (δH): 6.08–5.94 (m, 2H, H-4, H-11), 5.22 (m, 2H, H-2’), 4.99 (s, 1H, H-2), 3.69-
3.54 (m, 2H, H-1’), 2.76 (dq, 1H, J = 17.5, 2.6 Hz, H-14), 2.69 (dq, 1H, J = 17.5, 2.6 Hz, 
H-14), 2.19-2.05 (m, 2H, H-5), 1.74 (t, 3H, J = 2.7 Hz, H-18), 1.67-1.40 (m, 9H, OH, 
CH2), 1.22 (s, 3H, H-16 or H-17), 1.21 (s, 3H, H-16 or H-17), 1.00 (s, 3H, H-19).  
 
13C NMR (δC): 154.0 (C=O), 140.9 (C-3), 137.3 (C-11), 132.7 (C-4), 115.1 (C-2’), 88.1, 
78.2, 76.7, (C-13, C-12, C-1) 73.1 (C-2), 63.2 (C-1’), 45.4 (C-15), 35.9 (CH2), 35.5 (CH2), 
34.2 (CH2), 26.0 (C-8), 25.9 (C-19), 24.9 (C-5), 22.5 (C-14), 21.9 (C16 or 17), 20.3 (C16 
or C-17), 17.4 (CH2), 2.7 (C-18).  
 
HRMS Calcd for C22H32O4Na: 383.2193. Found: 383.2174. 
 
IR (film): 3483, 2935, 2872, 2332, 1799, 1464, 1344, 1199, 1043, 927, 767 cm-1. 
 
(4S,5S)-4-(but-2-yn-1-yl)-5-[(6S)-6-(3-hydroxypropyl)-6-methylcyclohex-1-en-1-yl]-4-
(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 214b. 
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[α]21.9 D: +9.0 (c 0.1, CH2Cl2). 
 
1H NMR (δH): 6.07–5.98 (dd, 1H, J = 17.4, 10.7 Hz, H-11), 5.85 (t, 1H, J = 3.9 Hz H-4), 
5.24-5.16 (m, 2H, H-2’), 5.02 (s, 1H, H-2), 3.61-3.53 (m, 2H, H-1’), 2.78 (dq, 1H, J = 
17.4, 2.6 Hz, H-14), 2.67 (dq, 1H, J = 17.4, 2.6 Hz, H-14), 2.13-2.04 (m, 2H, H-5), 1.72 (t, 
3H, J = 2.5 Hz, H-18), 1.59-1.43 (m, 5H, CH2), 1.42-1.30 (m, 3H, CH2), 1.21 (s, 3H, H-16 
or H-17), 1.19 (s, 3H, H-16 or H-17), 1.06 (s, 3H, H-19).  
 
13C NMR (δC): 153.9 (C=O), 141.0 (C-3), 139.1 (C-11), 130.8 (C-4), 115.0 (C-2’), 88.1, 
78.3, 77.7 (C-13, C-12, C-1), 73.0 (C-2), 62.4 (C-1’), 45.2 (C-15), 35.5 (CH2), 34.5 (CH2), 
33.9 (CH2), 25.9 (C-8), 24.8 (C-19), 23.9 (C-5), 22.6 (C-14), 21.9 (C16 or 17), 20.2 (C16 
or C-17), 17.2 (CH2), 2.7 (C-18).  
 
HRMS Calcd for C22H32O4Na: 383.2193. Found: 383.2179. 
 
IR (film): 3421, 2939, 2870, 1797, 1417, 1344, 1201, 1057, 927, 767 cm-1. 
 
 
(4R,5R)-4-(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-
en-1-yl]-4-(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 179a and (4S,5S)-4-
(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-4-
(2-methylbut-3-en-2-yl)-1,3-dioxolan-2-one 179b. 
 
 
 
To a solution of 214a (50 mg, 0.13 mmol) in tetrahydrofuran (3 mL) was added o-
nitrophenylselenocyanate (74 mg, 0.33 mmol, 2.4 equiv) and tributylphosphine (80 μL, 
0.33 mmol, 2.4 equiv).  The mixture was stirred at room temperature for 20 min before 
being quenched with water.  The aqueous layer was extracted with diethyl ether and the 
combined organic extracts were washed with brine, dried over anhydrous magnesium 
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sulfate, filtered and concentrated in vacuo.  The crude brown oil was used without further 
purification. 
 
A solution of ammonium molybdate (86 mg) in water (6 mL), and 30% aqueous hydrogen 
peroxide (3 mL) was prepared.  This solution (1.7 mL) was added at -10 °C to a solution of 
the crude brown oil in tetrahydrofuran (3 mL).  The mixture was stirred at this temperature 
for 20 min (no longer).  The reaction was quenched with water and the aqueous layer was 
extracted with diethyl ether.  The combined organic extracts were washed with brine, dried 
over anhydrous magnesium sulfate, filtered and concentrated in vacuo.  The crude mixture 
was purified by flash column chromatography (diethyl ether/petroleum ether: 5/95) and 
gave 179a as a pale yellow oil (44.0 mg, 93% yield). 
 
The same procedure was used with 214b (44.0 mg, 0.15 mmol) and gave the desired triene 
179b as a pale yellow oil (42.0 mg, 81%). 
 
(4R,5R)-4-(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-4-(2-
methylbut-3-en-2-yl)-1,3-dioxolan-2-one 179a. 
 
 
 
[α]22 D: +19.4 (c 1.2, CH2Cl2). 
 
1H NMR (δH): 6.03  (dd, J = 17.8, 10.6 Hz, 1H, H-11), 5.95 (t, 1H, J = 4.0 Hz, H-4), 5.81–
5.69 (m, 1H, H-10), 5.26-5.19 (m, 2H, H-2’), 5.10-5.00 (m, 3H, H-1’, H-2), 2.78 (dq, 1H, J 
= 17.5, 2.6 Hz, H-14), 2.70 (dq, 1H, J = 17.5, 2.6 Hz, H-14), 2.30-2.23 (m, 1H, H-9), 2.17-
2.09 (m, 3H, H-5, H-9), 1.74 (t, 3H, J = 2.6 Hz, H-18), 1.67-1.55 (m, 2H, CH2), 1.43-1.32 
(m, 2H, CH2) 1.23 (s, 3H, H-16 or H-17), 1.22 (s, 3H H-16 or H-17), 1.01 (s, 3H, H-19).  
 
13C NMR (δC): 154.0 (C=O), 141.9 (C-11), 137.3 (C-3), 133.1 (C-10), 132.3 (C-4), 117.1 
(C-1’), 115.0 (C-2’), 88.0, 78.2, 76.8 (C-13, C-12, C-1), 76.3 (C-2), 45.4 (C-15), 44.1 (C-
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8), 36.0 (C-9), 34.7 (C-5), 25.1 (C-6), 24.7 (C-19), 22.5 (C-14), 22.0 (C16 or 17), 20.3 
(C16 or C-17), 17.2 (C-7), 2.7 (C-18).  
 
MS: 343 (M+H)+, 281. 
 
IR (film): 2933, 2850, 1801, 1448, 1325, 1193, 1043, 1109 cm-1. 
 
(4S,5S)-4-(But-2-yn-1-yl)-5-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-4-(2-
methylbut-3-en-2-yl)-1,3-dioxolan-2-one 179b. 
 
 
 
[α]21.9 D: -66.4 (c 1.1, CH2Cl2). 
 
1H NMR (δH): 6.05 (dd, J = 17.5, 10.2 Hz, 1H, H-11), 5.89 (t, 1H, J = 4.0 Hz, H-4), 5.79–
5.68 (m, 1H, H-10), 5.26-5.18 (m, 2H, H-2’), 5.08-4.96 (m, 3H, H-1’, H-2), 2.79 (dq, 1H, J 
= 17.5, 2.6 Hz, H-14), 2.70 (dq, 1H, J = 17.5, 2.6 Hz, H-14), 2.23-2.15 (m, 1H, H-9), 2.14-
2.01 (m, 3H, H-5, H-9), 1.73 (t, 3H, J = 2.6 Hz, H-18), 1.68-1.53 (m, 1H, CH2), 1.38-1.29 
(m, 3H, CH2) 1.23 (s, 3H, H-16 or H-17), 1.22 (s, 3H H-16 or H-17), 1.07 (s, 3H, H-19).  
 
13C NMR (δC): 153.8 (C=O), 141.0 (C-11), 138.7 (C-3), 133.2 (C-10), 131.3 (C-4), 117.0 
(C-1’), 115.0 (C-2’), 88.1, 78.5, 77.5 (C-13, C-12, C-1), 73.1 (C-2), 45.3 (C-15), 42.9 (C-
8), 36.1 (C-9), 34.0 (C-5), 24.9 (C-6), 24.1 (C-19), 22.7 (C-14), 22.1 (C16 or 17), 20.4 
(C16 or C-17), 17.1 (C-7), 2.7 (C-18).  
 
MS: 343 (M+H)+, 281. 
 
IR (film): 3421, 2976, 2860, 1803, 1450, 1325, 1193, 1041 cm-1. 
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(1R,2R)-2-Hydroxy-1-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-
yl]-2-(2-methylbut-3-en-2-yl)hex-4-yn-1-yl benzoate 215a and (1S,2S)-2-
Hydroxy-1-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-2-(2-
methylbut-3-en-2-yl)hex-4-yn-1-yl benzoate 215b. 
 
 
 
To a solution of 179a (46 mg, 0.13 mmol) in tetrahydrofuran (3 mL) at -78˚C was added 
phenyllithium (1.72 mL, 0.7 M in ether, 1.17 mmol, 9.0 equiv).  The mixture was stirred at 
this temperature for 1.5 h before being quenched with saturated aqueous sodium hydrogen 
carbonate.  The aqueous phase was extracted with diethyl ether and the combined organic 
extracts were washed with brine, dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo.  Purification by flash column chromatography (diethyl 
ether/petroleum ether: 5/95) gave 215a as a pale yellow oil (30 mg, 54 %). 
 
The same procedure was used with 179b (42 mg, 0.12 mmol) and gave the desired 
benzoate 215b as a pale yellow oil (36 mg, 70%). 
 
(1R,2R)-2-Hydroxy-1-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-2-(2-
methylbut-3-en-2-yl)hex-4-yn-1-yl benzoate 215a. 
 
 
 
[α]24 D: +65.0 (c 0.6, CH2Cl2). 
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1H NMR (δH): 8.00 (d, 2H, J = 7.5 Hz, H-Ar), 7.54 (t, 1H, J = 7.5 Hz, H-Ar), 7.43 (t, 2H, J 
= 7.5 Hz, H-Ar), 6.44 (t, 1H, J = 4.0 Hz, H-4), 6.09 (dd, 1H, J = 17.7, 10.8 Hz, H-11), 5.81 
(s, 1H, H-2), 5.74-5.62 (m, 1H, H-10), 5.01-4.92 (m, 2H, H-2’), 4.89 (d, 1H, J = 17.7 Hz, 
H-1’), 4.71 (d, 1H, J = 10.7 Hz, H-1’), 2.89 (s, 1H, OH), 2.67 (dq, 1H, J = 17.0, 2.6 Hz, H-
14), 2.56 (dq, 1H, J = 17.0, 2.6 Hz, H-14), 2.46 (m, 1H, H-9), 2.16-2.07 (m, 3H, H-5, H-9), 
1.82 (t, 3H, J = 2.6 Hz, H-18), 1.65-1.50 (m, 4H, H-6, H-7), 1.22 (s, 3H, H-16 or H-17), 
1.14 (s, 3H, H-16 or H-17), 1.11 (s, 3H, H-19).  
 
13C NMR (δC): 163.9 (C=O), 144.6 (C-11) 141.5 (C-3), 134.3 (C-10), 131.8 (C-4), 131.0 
(C-Ar), 130.3 (C-Ar), 129.0 (C-Ar), 127.5 (C-Ar), 116.2 (C-1’), 110.5 (C-2’), 79.5, 77.0, 
76.3 (C-13, C-12, C-1), 74.9 (C-2), 45.0 (C-15), 43.2 (C-8), 36.0 (C-9), 34.2 (C-5), 25.5 
(C-6), 24.9 (C-19), 24.5 (C-14), 23.3 (C16 or 17), 22.0 (C16 or C-17), 17.1 (C-7), 2.9 (C-
18).  
 
HRMS Calcd for C28H37O3: 421.6029. Found: 421.6021.  MS: 421 (M+H)+, 299. 
 
IR (film): 3541, 3064, 2931, 2864, 1712, 1446, 1311, 1267, 1105 cm-1. 
 
(1S,2S)-2-Hydroxy-1-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-2-(2-
methylbut-3-en-2-yl)hex-4-yn-1-yl benzoate 215b. 
 
 
 
[α]24 D: -33.2 (c 1.2, CH2Cl2). 
 
1H NMR (δH): 8.00 (d, 2H, J = 7.7 Hz, H-Ar), 7.55 (t, 1H, J = 7.7 Hz, H-Ar), 7.44 (t, 2H, J 
= 7.7 Hz, H-Ar), 6.39 (t, 1H, J = 4.0 Hz, H-4), 6.09 (dd, 1H, J = 17.4, 10.6 Hz, H-11), 5.85 
(s, 1H, H-2), 5.83-5.75 (m, 1H, H-10), 5.05-4.97 (m, 2H, H-2’), 4.97 (d, 1H, J = 17.6 Hz, 
H-1’), 4.91 (d, 1H, J = 10.7 Hz, H-1’), 2.88 (s, 1H, OH), 2.63 (dq, 1H, J = 17.0, 2.6 Hz, H-
14), 2.56 (dq, 1H, J = 17.0, 2.6 Hz, H-14), 2.47-2.39 (m, 1H, H-9), 2.25-2.17 (m, 1H, H-9), 
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2.14-2.04 (m, 2H, H-5), 1.81 (t, 3H, J = 2.6 Hz, H-18), 1.66-1.51 (m, 4H, H-6, H-7), 1.24 
(s, 3H, H-16 or H-17), 1.17 (s, 3H, H-16 or H-17), 1.12 (s, 3H, H-19).  
 
13C NMR (δC): 164.0 (C=O), 144.8 (C-11) 141.6 (C-3), 134.3 (C-10), 131.9 (C-4), 131.0 
(C-Ar), 130.2 (C-Ar), 128.8 (C-Ar), 127.4 (C-Ar), 116.4 (C-1’), 110.9 (C-2’), 79.5, 77.2, 
76.7 (C-13, C-12, C-1), 75.0 (C-2), 44.9 (C-15), 43.4 (C-8), 35.8 (C-9), 34.8 (C-5), 25.8 
(C-6), 24.9 (C-19), 24.6 (C-14), 23.2 (C16 or 17), 22.2 (C16 or C-17), 17.0 (C-7), 2.8 (C-
18).  
 
HRMS Calcd for C28H37O3: 421.6029. Found: 421.6021.   
 
IR (film): 3543, 2931, 2359, 1716, 1450, 1315, 1269, 1111 cm-1. 
 
 
(1S,2S,8S,10E)-1-Hydroxy-8,12,14,14- 
tetramethyltricyclo[9.3.1.0{3,8}]pentadeca- 3,10,12-trien-2-yl benzoate 
216. 
 
 
 
To a thoroughly degassed solution of 215b (14 mg, 33 μmol) in toluene (3 mL) was added 
second generation Grubbs’ catalyst (1.4 mg, 1.6 μmol, 5 mol%).  The mixture was stirred 
at reflux and monitored by TLC.  After 1 h the mixture was cooled and the solvent was 
removed in vacuo and the crude mixture was purified by flash column chromatography and 
gave 216 as a colourless oil (diethyl ether/petroleum ether: 8 mg, 57%).   
 
[α]24 D: +14.8 (c 0.8, CHCl3). 
 
1H NMR (δH): 8.00 (d, 2H, J = 7.8 Hz, H-Ar), 7.56 (t, 1H, J = 7.8 Hz, H-Ar), 7.45 (t, 2H, J 
= 7.8 Hz, H-Ar), 6.12 (m, 1H, H-4), 5.77 (t, 1H, J = 8.0 Hz, H-10), 5.47 (s, 1H, H-2), 4.97 
(m, 1H, H-11), 2.84 (dd, 1H, J = 12.7, 8.4 Hz, H-9), 2.66 (d, 1H, J = 11.4 Hz, H-14), 2.33 
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(s, 1H, OH), 2.29 (d, 1H, J = 11.6 Hz, H-14), 2.18 (dt, 1H, J = 18.4, 5.3 Hz, H-5), 2.05-
1.93 (m, 1H, H-5), 1.80 (s, 3H, H-18), 1.71 (dd, 1H, J = 12.9, 7.5 Hz, H-9), 1.63-1.57 (m, 
2H, H-6, H-7), 1.46-1.35 (m, 2H, H-6, H-7), 1.19 (s, 3H, H-16 or H-17), 1.13 (s, 3H, H-16 
or H-17), 0.89 (s, 3H, H-19).  
 
13C NMR (δC): 163.4 (C=O), 143.1 (C-11), 138.0 (C-3), 132.8 (C-13), 132.0 (C-10), 130.8 
(C-4), 130.0 (C-Ar), 128.5 (C-Ar), 127.9 (C-Ar), 127.6 (C-Ar), 121.5 (C-12), 78.1 (C-1), 
72.0 (C-2), 42.2 (C-15), 42.0 (C-8), 40.8 (C-7), 38.3 (C-9), 33.5 (C-14), 26.5 (C-19), 25.8 
(C-5), 25.0 (C-16 or C-17), 23.6 (C16 or C-17), 17.5 (C-6), 16.9 (C-18).  
 
HRMS Calcd for C26H32O3: 392.2351. Found: 392.2348. 
 
IR (film): 3542, 2927, 1718, 1451, 1320, 1266, 1113, 1068 cm-1. 
 
 
(4S,5S)-6,6,9-Trimethyl-4-[(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-
en-1-yl]-1,3-dioxaspiro[4.6]undeca-7,9-dien-2-one 221. 
 
 
 
To a solution of 179b (33.0 mg, 96.4 mmol) in methanol (2 mL) with 2 drops of water was 
added AuClPPh3 (2.4 mg, 4.8 μmol, 5 mol%) and AgSbF6 (3.3 mg, 9.6 μmol, 10 mol%).  
The reaction was stirred for 30 min at room temperature before being quenched with water.  
The aqueous layer was extracted with diethyl ether and the combined organic extracts were 
washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated in 
vacuo.  Purification by flash column chromatography (diethyl ether/petroleum ether: 5/95) 
gave the product 221 as a yellow oil (14.0 mg, 40%). 
 
[α]24 D: -54.9 (c 1.0, CHCl3). 
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1H NMR (δH): 6.13 (br d, 1H, J = 15.8 Hz, H-11), 6.02 (t, 1H, J = 4.0 Hz, H-4), 5.77-5.66 
(m, 1H, H-10), 5.65-5.55 (dq, 1H, J = 15.6, 6.7 Hz, H-2’), 5.38 (br s, 1H, H-13), 5.14 (br s, 
1H, H-2), 4.98 (m, 2H, H-1’), 2.85-2.59 (m, 2H, H-14), 2.15-2.06 (m, 3H, H-5, H-9), 2.05-
1.98 (m, 1H, H-9), 1.78 (d, 3H, J = 6.6 Hz, H-18), 1.69-1.56 (m, 4H, H-6, H-7), 1.19 (s, 
3H, H-19), 1.11 (2s, 6H, H-16, H-17).  
 
13C NMR (δC): 154.2 (C=O), 140.9 (C-11), 135.5 (C-3), 134.1 (C-10), 132.7 (C-12), 129.4 
(C-13), 126.9 (C-4), 126.3 (C-2’), 117.3 (C-1’), 95.6 (C-1), 75.0 (C-2), 50.7 (C-8), 43.2 
(C-9), 39.2 (C-7), 36.0 (C-15), 33.9 (C-14), 24.8 (C-5), 24.0 (C-18), 23.9 (C-16 or C-17), 
19.1 (C16 or C-17), 17.3 (C-19), 17.2 (C-6).  
 
HRMS Calcd for C22H30O3: 342.2195. Found: 342.2192. 
 
IR (film): 3020, 2935, 1785, 1447, 1331, 1215, 1175, 1052 cm-1. 
 
 
(S)-[(2S)-5RS-Methoxy-5-methyl-2-(2-methylbut-3-en-2-yl)oxolan-2-
yl][(6S)-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]methyl Benzoate 
222. 
 
 
 
To a solution of 215b (13 mg, 30 μmol) in methanol (2 mL) with 2 drops of water was 
added AuClPPh3 (2.4 mg, 4.8 μmol, 5 mol%) and AgSbF6 (3.3 mg, 9.6 μmol, 10 mol%).  
The reaction was stirred for 30 min at room temperature before being quenched with water.  
The aqueous layer was extracted with diethyl ether and the combined organic extracts were 
washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated in 
vacuo.  Purification by flash column chromatography (diethyl ether/petroleum ether: 5/95) 
gave the hemiketal 222 as a mixture of 1:1.5 diastereomers as a yellow oil (1:1.5/ minor 
(md): major (Md)) (7 mg, 53%). 
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1H NMR (δH): 8.07 (dd, 2H, J = 8.1 Hz, H-Ar (md)), 8.07 (dd, 2H, J = 7.8 Hz, H-Ar (Md)), 
7.55-7.50 (m, 2H, H-Ar (Md, md)), 7.41-7.40 (m, 4H, H-Ar (Md, md)), 6.24-6.15 (m, 2H, 
H-4 (Md), H-11 (Md)), 6.12 (dd, 1H, J = 17.6, 10.8 Hz, H-11 (md)), 6.05 (t, 1H, J = 3.9 
Hz, H-4 (md)), 5.89-5.78 (m, 3H, H-10 (Md, md), H-2 (md)), 5.70 (s, 1H, H-2 (Md)), 5.07-
4.99 (m, 4H, H-2’ (Md, md)), 4.98-4.89 (m, 2H, H-1’ (md)), 4.82 (d, 1H, J = 17.7 Hz, H-1’ 
(Md)), 4.67 (d, 1H, J = 10.5 Hz, H-1’ (Md)), 3.32 (s, 3H, OMe (Md)), 3.22 (s, 3H, OMe 
(md)), 2.66-2.59 (m, 1H, H-14 (md)), 2.57-2.51 (m, 1H, H-14 (Md)), 2.28-2.21 (m, 2H, H-
14, H-13 (md)), 2.17-2.11 (m, 2H, H-14, H-13 (Md)), 2.06-2.00 (m, 5H, H-13, H-9, H-5 
(md)), 2.00-1.94 (m, 5H, H-13, H-9, H-5, (Md)), 1.61-1.57 (m, 4H, H-6, H-7 (Md), (md)), 
1.55 (s, 6H, H-18, H-19, (md)), 1.55-1.52 (m, 4H, H-6, H-7 (Md), (md)), 1.51 (s, 6H, H-
18, H-19, (Md)), 1.16 (s, 6H, H-16, H-17 (md)), 1.12 (d, 6H, H-16, H-17 (Md)).  
 
13C NMR (δC): 166.8 (C=O), 166.4 (C=O), 147.0 (C-11), 146.3 (C-11), 143.9 (C-3), 135.7 
(C-10), 135.2 (C-10), 132.6 (C-4), 132.5 (C-4), 131.7 (C-Ar), 130.5 (C-Ar), 129.8 (C-Ar), 
129.7 (C-Ar), 128.3 (C-Ar), 117.5 (C-1’), 117.1 (C-1’), 109.1 (C-2’), 94.4 (C-12), 93.8 (C-
12), 79.6 (C-1), 77.7 (C-1), 74.0 (C-2), 73.5 (C-2), 50.3 (OMe), 49.5 (OMe), 45.2 (C-8), 
43.9 (C-8), 39.3 (C-9), 37.1 (C-15), 37.0 (C-15), 35.6 (C-13), 31.5 (C-5), 31.4 (C-5), 30.1 
(C-7), 30.0 (C-7), 25.9 (C-19), 25.7 (C-19), 25.5 (C-14), 25.4 (C-14), 25.2 (C-18), 24.3 (C-
18), 24.0 (C-16 or C-17), 23.0 (C-16 or C-17), 22.1 (C-16 or C-17), 18.0 (C-6), 17.9 (C-6).   
 
HRMS Calcd for C29H40O4Na: 475.2819. Found: 475.2810. 
 
IR (film): 2916, 2849, 1715, 1461, 1376, 1315, 1217, 1176, 1097, 1068 cm-1. 
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